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Abstract
Tyrosine rich acidic matrix protein (TRAMP) is a 22 kilodalton protein that co-
purifies with lysyl oxidase from porcine skin. Human and bovine equivalents have
also been identified. The biological significance of TRAMP in the extracellular
matrix is not understood, although the bovine form has been shown to interact with
the dermatan sulphate proteoglycan, decorin and alter its effects on cell adhesion.
Previously, TRAMP has been shown to accelerate collagen I fibril formation in vitro
at sub-stoichiometric molar ratios of TRAMP to collagen.
A number of purification strategies were performed in an attempt to produce highly
purified, active TRAMP free from lysyl oxidase for fibrillogenesis and enzymatic
studies. Unsuccessful methods included hydrophobic interaction chromatography,
affinity purification on amino-hexyl Sepharose and preparative isoelectric focusing.
TRAMP was eventually purified by DEAE anion exchange followed by Superdex-75
size exclusion (in the presence of urea) and Mono Q FPLC anion exchange
chromatography. Yields of lOpg of TRAMP per g wet weight starting material were
obtained.
TRAMP purified as above was active in fibrillogenesis assays using the 'warm start'
technique, in buffers containing 30mM TES, 30mM NaiHPCE, 135mM NaCl pH 7.4.
The acceleratory effect of TRAMP on collagen I fibril formation was also observed
when the phosphate concentration was lowered to lOmM and when TES was
removed. TRAMP has previously been shown to bind to in vitro reconstituted
collagen fibrils if present during their formation. Reducing the phosphate
concentration decreased the amount of TRAMP associated with collagen I fibrils in
co-sedimentation assays, whilst subsequent removal of TES had no effect on TRAMP
binding to collagen I fibrils. Preliminary observations also suggested that treatment of
TRAMP with sulphatase had no effect on the ability of TRAMP to accelerate collagen
I fibril formation. A solid phase assay showed TRAMP to bind collagen I monomers
with a higher affinity than fibrils suggesting a role for TRAMP in the early,
nucleation phase of fibril formation. TRAMP was unable to reverse the inhibitory
effect of decorin on fibril formation. The presence of decorin had no effect on
vin
TRAMP binding to collagen monomers in solid phase assays but led to an increase in
the amount of TRAMP associated with collagen fibrils in co-sedimentation assays.
Attempts to identify specific binding sites for TRAMP on in vitro reconstituted
collagen I fibrils by immunogold labelling and electron microscopy were
unsuccessful.
Western blot analysis of murine tissues confirmed previous reports that TRAMP was
present in lung and skeletal muscle and absent from brain and spleen. In addition,
TRAMP was found in bladder, ovary, testes and duodenum. Immunocytochemistry of
21 day mouse tissues with affinity purified antibody to porcine TRAMP showed it to
be present in the dermis of the skin, surrounding skeletal muscle fibres, within the
myocardium, endocardium and supporting tissue of the heart, in the sclera of the eye
and within the intestinal microvilli in duodenum. Previous amino acid sequence
analysis suggested that TRAMP may be a copper-dependent amine oxidase, due to the
presence of the putative topaquinone consensus sequence N-Y-D. However, TRAMP
showed no amine oxidase activity on either benzylamine or [4,5-3H] lysine labelled
elastin or collagen substrates.
It is proposed that TRAMP plays an important role in the early, nucleation stages of
fibril formation by binding two adjacent collagen monomers and thus stabilising the
nuclei. The presence of TRAMP at the end of the growing fibril may also serve to
direct cells to sites for collagen deposition.
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1.1 The Extracellular Matrix
The extracellular matrix (ECM) is an organised meshwork surrounding cells in
tissues. The components of this intercellular network are synthesised by the cells to
provide them with structural support and protection from external physical stress.
The relationship between the cells and the matrix is dynamic. The ECM interacts
with the cells to regulate their shape, growth, differentiation and migration. In return,
the cells modulate the composition and organisation of the ECM.
The variations in relative amounts of the ECM components and the way in which
they are organised give an amazing diversity of forms, highly adapted to the
functional requirements of the particular tissue. Understanding of the complex
interactions taking place to achieve such diversity is incomplete. The following
review discusses some of the various components and their roles and then goes on to
discuss what is known about interactions between them. For additional information
on matrix glycoproteins and other ECM components see Yamada (1991) and Ayad et
al. (1994).
1.2 Collagen
Collagen comprises a third of the total protein mass in vertebrates. It is not surprising
therefore, that it is also one of the major components of the extracellular matrix, with
roles in structural support, cell adhesion and cell migration (Brown and Timpl, 1995).
The general definition of a collagen is that it is a protein containing one or more
domains comprised of 3 polypeptide chains folded to form a right-handed super triple
helix, which is able to form supramolecular assemblies in the extracellular space. At
the amino acid level each of these polypeptide chains consists of a repeating Gly-X-Y
unit where X is commonly proline and Y commonly hydroxyproline. It also contains
a high proportion of hydroxylysine residues. The polypeptide chains, also known as a
chains, may or may not be identical (Kielty et al., 1993).
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1.2.1 Classification of Collagen Types
Collagen is not a single molecule but a large heterogeneous class of molecules with a
tissue specific distribution (Table 1.1). Over 18 different collagen types have been
identified (for reviews see Hulmes, 1992; Mayne and Brewton, 1993; Kadler, 1994;
Prockop and Kivirikko, 1995). These were originally classified in order of discovery,
using a numbering system with Roman numerals for collagen type and Arabic
numerals for individual polypeptide or a-chains. Collagens can also be classified
according to their supramolecular structure into fibrillar and non-fibrillar collagens
(Hulmes, 1992). The fibrillar collagens (types I, II, III, V and XI) form rod-like fibrils
with a characteristic 64-67nm (D-) repeating banding pattern when viewed by
electron microscopy. The banding pattern is the result of the arrangement of
neighbouring collagen molecules in a quarter-staggered array (Figure 1.1; Kadler,
1994). The most abundant and well characterised of the fibrillar collagens is collagen
I which is found in skin, tendon, bone, cornea and the vascular system. Collagen II is
the major cartilage collagen and is also found in embryonic cornea and vitreous
humour whilst collagen III has a widespread tissue distribution similar to that of
collagen I (for review see Hulmes, 1992). Collagen V forms heterotypic fibrils with
collagen I and thus has a similar tissue distribution (Birk et al., 1988; Birk and
Lisenmayer, 1994). In a similar manner, collagen XI is localised to tissues containing
collagen II (Mendler et al., 1989).
The non-fibrillar collagens can be further sub-divided into the Fibril Associated
Collagens with Interrupted Triple helices or FACIT (collagens IX, XII and XIV), the
network forming collagens (IV and VII), a microfibrillar (beaded) collagen (VI), the
short chain collagens (VIII and X) and two new sub-groups, the transmembrane
collagens (XVII and XIII) and the MULTIPLEXINS (XV and XVIII; multiple triple
helix domains with interruptions; Hulmes, 1992; Pihlajaniemi and Rehn, 1995).
FACIT collagens have 'multiple domains' and as the name suggests are localised at
specific sites on the surface of collagen fibrils (Shaw and Olsen, 1991). For example,
collagen IX is covalently linked to collagen II (van der Rest and Mayne, 1988). It is
postulated that FACIT collagens may form a link between fibrillar collagens and
3




I al(I), oc2(I) Fibrillar Bone, skin, cornea,
lung, tendon
II a 1 (II) Fibrillar Cartilage, vitreous
humour





V al(V), a2(V), a3(V) Fibrillar Collagen I containing
tissue
VI al(VI), a2(VI), a3(VI) 'Beaded' microfibrils Most connective tissues
VII al(VII) Anchoring fibrils Basement membrane
(skin, oral mucosa,
cervix)
VIII al(VIII), a2(VIII) Hexagonal arrays Descemet's membrane,
endothelial cells




X al(X) Hexagonal arrays Hypertrophic and
mineralising zones of
cartilage








XIII a 1 (XIII) ? transmembrane most connective
tissues?




XV al(XV) only? unknown Widespread
XVI al(XVI) only? unknown Human fibroblasts
(from cDNA)
XVII a 1 (XVII) only? transmembrane Human skin (from
cDNA)
XVIII al (XVIII) only? unknown Widespread, most
abundant in liver and
lung
Table 1.1. Vertebrate collagens.
References: Types I-XIV (Hulmes, 1992; Brown and Timpl, 1995), Types XV-XVIII









Figure 1.1. Schematic diagram illustrating the relationship between the
staggered arrangement of collagen monomers within a fibril (a) and the
banding patterns observed by electron microscopy of negatively (b) and
positively (c) stained collagen fibrils. Electron micrographs were
reproduced from Mould et al. (1990). For negative staining (b) fibrils were
stained with 1% phosphotungstic acid, (pH 7.4) which permeates the fibrils
and becomes trapped within the 'gap' zones. For positive staining (c) fibrils
were stained with 1% phosphotungstic acid, (pH 2.2), followed by by 1%
uranyl acetate, (pH 4.4). The banding pattern observed after positive staining




other matrix components. The network forming collagens are found close to or as
part of basement membranes, which are extracellular sheet-like structures underlying
epithelial and endothelial cells (van der Rest and Garrone, 1991). Collagen VI has a
widespread distribution amongst connective tissues and forms fibrils with 1 lOnm
periodicity. The microfibrillar 'beads on a string' appearance of collagen VI is due to
the anti-parallel association of molecules into dimers which can then laterally
associate into tetramers (Timpl and Engel, 1987). Short chain collagen molecules are
approximately half the length of the fibrillar collagens and form highly organised
supramolecular hexagonal arrays. The hexagonal array formed by collagen X is
believed to act as a scaffold during the replacement of cartilage by bone in
hypertrophic bone (Schmid and Linsenmeyer, 1990). The classification of collagens
XIII and XVII as transmembrane collagens was originally based on their cDNA
sequences and to date, this is the only evidence that collagen XIII is embedded in the
membrane. By contrast, immunolocalisation studies have confirmed that collagen
XVII is a non-secreted transmembrane protein (Hopkinson and Jones, 1996). The
MULTIPLEXINS are characterised by multiple non-collagenous domains within
collagenous sequences and also a unique pattern of four cysteine residues in the
C-terminal non-collagenous domain. They have a widespread distribution throughout
connective tissues but little is known about their structure or functions since they
have yet to be characterised at the protein level (Rehn and Pihlajaniemi, 1996).
1.2.2 Post-translational modifications of collagen I
Collagen I is synthesised as individual procollagen chains and undergoes a number of
post-translational modifications within the endoplasmic reticulum prior to secretion
from the cell. These include hydroxylation of proline and lysine residues to
hydroxyproline and hydroxylysine respectively, glycosylation of hydroxylysine
residues and, finally, chain association and disulphide bonding. The collagen
molecule is secreted into the extracellular matrix as a soluble precursor molecule
(procollagen) containing a central triple helical domain of 300nm in length and also
amino and carboxyl terminal propeptides (Kivirikko and Myllyla, 1985; Kadler,
1994). These propeptide regions are believed to be important for initiation of triple
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helix formation, and maintaining the solubility of the precursor molecule (Engel and
Prockop, 1991). Removal of the propeptides by specific procollagen N- and
C-proteinases reduces the solubility of the collagen molecule and initiates the
assembly of collagen monomers into fibrils (Section 1.7.2). Both these proteinases
are neutral, zinc/calcium-dependent metalloproteinases (Hojima et ai, 1985; 1989).
The procollagen I N-proteinase has been isolated as a 500kDa complex from chicken
tendon and as a 107kDa monomer from bovine skin (Hojima et al., 1989; Colige et
al., 1995). It only cleaves the amino propeptide from native, triple helical procollagen
(Kohn et al., 1974; Tuderman et al., 1978). In contrast, the monomeric, lOOkDa
procollagen I C-proteinase is able to cleave the carboxyl propeptide from both native
and denatured substrates (Goldberg et al., 1975; Hojima et al., 1985). The activity of
the C-proteinase is increased in the presence of a 55kDa procollagen C-proteinase
enhancer glycoprotein (PCPE; Adar et al., 1986). Also of interest is the recent
discovery that the C-proteinase is identical to bone morphogenetic protein I (BMP-I;
Kessler et al., 1996; Li et al., 1996; Wozney et al., 1988). Whether the effect of
C-proteinase/BMP-1 on bone morphogenesis is due to its C-proteinase activity or an
as yet undefined property of the enzyme remains to be determined. In addition, recent
evidence from the cDNA sequence of procollagen I N-proteinase, suggests that it
may also play a role in development (Colige et al., 1997).
The action of the N- and C-proteinases does not remove all the non-helical regions
from the collagen monomer. Small telopeptides remain at the N- and C-termini
which are important not only for assembly into fibrils but also because they contain
lysine residues on which lysyl oxidase acts to initiate the cross-linking of
neighbouring molecules to stabilise collagen fibrils (section 1.4).
1.3 Elastin
Elastin is the major constituent ofmature elastic fibres and is largely responsible for
the reversible extensibility (or elastic recoil) of many tissues such as aorta, lung and
ligaments. Within the elastic fibre, elastin is found as a polymer surrounded by a
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peripheral mantle of microfibrils containing amongst other proteins, the glycoprotein
fibrillin (Mecham and Heuser, 1991; Rosenbloom et ai, 1993).
Elastin is a highly hydrophobic protein which is synthesised as a soluble molecule
known as tropoelastin. This 72kDa protein has an unusual structure, containing
alternating hydrophobic and hydrophilic regions (Foster et al., 1973; Bressan et al.,
1987; Raju and Anwar, 1987; Indik et al, 1987). The hydrophilic regions contain
potential crosslinking sites which consist of two lysine residues within a polyalanine
sequence. In an a-helical conformation these lysine residues would be orientated on
the same side of the helix and would thus be available for the formation of
tetra-functional, interchain crosslinks initiated by lysyl oxidase (section 1.4.6). The
hydrophobic regions, meanwhile, are believed to form a random coil structure.
Together these two regions form the basis of the elastic recoil property of elastin
(Mecham and Heuser, 1991).
1.4 Lysyl oxidase
Lysyl oxidase (E.C 1.4.3.13) is a copper amine oxidase (CAO; section 1.4.5) which
has been isolated and characterised from a range of vertebrate tissues including
human placenta, bovine aorta, porcine skin, rat lung and chick aorta and cartilage (for
reviews see Kagan and Trackman, 1991; Kagan, 1994). In mammalian tissue, the
mature enzyme has a molecular mass of between 29-34kDa whilst chick aortic lysyl
oxidase has a reported molecular mass of 59-6lkDa (Kuivaniemi et al., 1984; Kagan
et al., 1979; Shackleton and Hulmes, 1990a; Romero-Chapman et al., 1991;
Cronshaw et al., 1995; Narayanan et al., 1974; Harris et al., 1974). Evidence also
exists for the formation of multimers of lysyl oxidase of up to lOOkDa (Kagan et al.,
1979).
Four variants of lysyl oxidase have been identified which can be separated by DEAE
anion exchange chromatography (Stassen, 1976). The variants have almost identical
molecular weights and enzyme activities and they do not appear to be the result of
different glycosylation, phosphorylation or disulphide bonding patterns (Kagan et al.,
1979; Sullivan and Kagan, 1982; Williams and Kagan, 1985). It has thus been
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suggested that the variants are genetically distinct forms of lysyl oxidase (Kagan et
al. 1979). The recent discovery of a gene encoding for a lysyl oxidase-like (LO-L)
protein supports this hypothesis, though the molecular mass of the mature form of
LO-L is unknown (Kim et al., 1995).
1.4.1 Purification of lysyl oxidase
Initial attempts to purify lysyl oxidase were hampered by the low solubility and
instability of lysyl oxidase in neutral salt buffers (Pinnell and Martin, 1968).
Observations that the stability of lysyl oxidase was increased in the presence of urea
led to the widespread use of 4-6M urea both for the initial extraction of lysyl oxidase
and throughout the purification process (Narayanan et al., 1974). The majority of
purification strategies developed for lysyl oxidase have involved some kind of DEAE
anion exchange step in combination with collagen or elastin affinity columns
(Stassen, 1976; Harris et al., 1974). Additionally, many workers have used a final gel
filtration step on Sephacryl S-200 in the presence of urea (Kagan et al., 1979).
Purification has also been achieved by Sephacryl S-200 chromatography in the
absence of urea in which case lysyl oxidase interacts with the column and can be
eluted with urea (Shackleton and Hulmes, 1990a). Other less commonly used
purification steps include Cibacron blue dye chromatography, hydroxyapatite
chromatography and chromatofocusing (Williams and Kagan, 1985; Almassian et al.,
1991; Hans and Tanzer, 1979).
1.4.2 Structure of lysyl oxidase
The cDNA sequence of human placental lysyl oxidase encodes for a protein of 420
amino acids in length comprised of a 21 amino acid signal peptide, an N-terminal
propeptide and the 30kDa lysyl oxidase domain (Hamalainen et al., 1991). Three
potential N-glycosylation sites have been identified all of which are found within the
N-terminal propeptide (Hamalainen et al., 1991; Cronshaw et al., 1995). cDNA
sequences are also available for rat and chick aortic lysyl oxidase with overall
homologies of 84% and 81% respectively (Trackman et al., 1990; Wu et al., 1992a).
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The proteins are most highly conserved within the later (C-terminal) two thirds of the
molecule which comprises the sequence for the mature lysyl oxidase protein and
contains a number of sequences of interest. These include the sequence His-X4-Cys-
X5-Cys-X4-His which is similar to a consensus sequence for metal-binding proteins
and two sequences, Tyr-Gly-Tyr-His-Arg-Arg-Phe-Ala-Cys and Tyr-Thr-Gly-His-
His-Ala-Tyr, with similarities to certain copper binding sequences (Trackman et al.,
1990; Hamalainen et al., 1991). In addition, the first nine N-terminal residues of the
mature lysyl oxidase sequence (Asp-Asp-Pro-Tyr-Asn-Pro-Tyr-Lys-Tyr) are 78%
homologous with a tyrosine rich region within the proteoglycan fibromodulin (Asp-
Asp-Pro-Tyr-Asp-Pro-Tyr-Pro-Tyr) and it has been postulated that this sequence may
be important for the collagen binding properties of both these proteins (Cronshaw et
al., 1995). Lysyl oxidase is also highly homologous (89%) to the ras recision gene
(rrg) product which has been shown to counteract the transforming activity of ras\
thus, it is possible that lysyl oxidase also has tumour suppressor activity (Contente et
al., 1990; Kenyon et al., 1991).
1.4.3 Biosynthesis and post-translational modifications of lysyl oxidase
Evidence from cDNA sequencing, immunoprecipitation and pulse chase studies
suggests that lysyl oxidase is synthesised as a 46kDa preproenzyme. After cleavage
of the signal peptide the protein undergoes N-glycosylation at sites within the
propeptide region. The resulting 50kDa proenzyme is secreted and proteolytically
processed to the active unglycosylated 29kDa enzyme in the extracellular space
(Trackman et al., 1990, 1992; Cronshaw et al., 1995). Recent evidence suggests that
the proteinase involved in the processing of lysyl oxidase is procollagen I
C-proteinase (BMP-1; Panchenko et al., 1996; section 1.2.2). This implies dual
regulation of lysyl oxidase activity and fibril assembly. The function of the
propeptide region is still unclear although it is not necessary for secretion, proper
folding or activity of the mature enzyme (Kagan et al., 1995).
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1.4.4 Localisation of lysyl oxidase within tissues
Lysyl oxidase is found within the extracellular space (Siegel et al., 1978) and also in
the cytoplasm of a number of fibroblastic and non-fibroblastic cells (Wakasaki and
Ooshima, 1990). Attempts to localise lysyl oxidase at the ultrastructural level by
immunogold labelling and electron microscopy gave contradictory results. Kagan et
al. (1986) localised the enzyme to the interface between amorphous elastin and
microfibrils within elastic fibres of calf and rat aorta but were unable to identify lysyl
oxidase within collagen fibrils. In contrast, Baccarani-Contri et al. (1989) localised
lysyl oxidase to collagen fibres in human placental, aortic and skin tissues and found
no labelling of elastic fibre in the aorta and poor to no labelling of the elastic fibre in
placental and dermal tissue. When labelling did occur it was localised within elastin
as opposed to at the interface between elastin and microfibrils. It is possible that
these conflicting results are due to the isolation of antigenically different lysyl
oxidase species (for example, lysyl oxidase-like protein; section 1.4) from bovine
aorta and human placenta, with different substrate specificities (Baccarrani-Contri et
al., 1989; Kim et al., 1995). It should also be noted that the anti-human placental
lysyl oxidase anti-serum cross-reacts with a 24kDa protein that co-purifies with lysyl
oxidase. It is not known whether this protein is a true degradation product of lysyl
oxidase or an unrelated protein (Kuivaniemi et al., 1984).
1.4.5 Lysyl oxidase reaction
Copper amine oxidases (CAO) catalyse the oxidative deamination of amines to
aldehydes and have a requirement for copper (Wang et al., 1996). The CAO activity
of lysyl oxidase converts the e-amino group on specific lysine and hydroxylysine
residues in both collagen and elastin to their corresponding aldehyde (allysine or
hydroyallysine; Fig 1.2). The reaction requires molecular oxygen and results in the
release of H2O2 and NH3 (Williamson and Kagan, 1986). The exact role of copper is
unclear although it is required for the release of the aldehyde from the enzyme
complex (Gacheru et al., 1990). Lysyl oxidase also requires a second, carbonyl






















Figure 1.2. The reaction catalysed by lysyl oxidase. From Kagan, 1986.
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et al., 1991). Until recently, controversy has surrounded the exact nature of this
cofactor in lysyl oxidase and in CAOs as a whole (for review see Klinman, 1996). It
was previously believed that pyrroloquinoline quinone (PQQ) was the cofactor in
human placental (van der Meer and Duine, 1986) and bovine aortic (Williamson et
al., 1986) lysyl oxidase although the identification of topaquinone (TPQ) at the active
site of a range of other mammalian CAOs suggested that lysyl oxidase also contained
this cofactor (Janes et al., 1990, 1992). However, unlike the other CAOs studied,
lysyl oxidase does not contain the consensus amino acid sequence for the conversion
of tyrosine to TPQ (i.e. Asn-Tyr-Asp/Glu; Mu et al., 1992). Recently, bovine aortic
lysyl oxidase was found to contain a unique cofactor at its active site. This cofactor,
lysine tyrosylquinone (LTQ) is formed by crosslinking of lysine and tyrosine side
chains within lysyl oxidase and is the only example of a quinone cofactor formed by
crosslinking of two amino acid side chains (Wang et al., 1996).
1.4.6 Crosslink formation in collagen and elastin
The reaction catalysed by lysyl oxidase initiates a number of spontaneous reactions
which result in the formation of crosslinks between individual chains within a
collagen monomer (intramolecular) and between adjacent collagen monomers
(intermolecular). These cross links can be bi- or tri-functional (for reviews see Last et
al., 1990; Eyre et al., 1984). The bi-functional crosslinks can be divided into aldol
crosslinks, formed mainly by the condensation of 2 allysines to form the aldol
condensation product (ACP; Piez, 1968), and Schiff base crosslinks (Kuboki et al.,
1981). Schiff base crosslinks can occur between allysine and the e-amino group of
unoxidised lysine forming dehydrolysinonorleucine, between allysine and
hydroxylysine to form dehydrohydroxylysinonorleucine or between hydroxyallysine
and hydroxylysine forming dehydrodihydroxylysinonorleucine. Two major
tri-functional crosslinks occur in collagen, formed either by reaction of the ACP with
histidine to form aldol histidine (Mechanic et al., 1987; Yamauchu et al., 1987) or by
reaction of 2 hydroxyallysine residues with either lysine or hydroxylysine to form
3-hydroxypyridinium crosslinks (Fujimoto, 1977; Kagan, 1994).
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In elastin, -85% of the lysine residues are involved in crosslinking (Rosenbloom et
al., 1993). Aldol condensation product and dehydrolysinonorleucine crosslinks are
found in elastin but since hydroxylation of lysine residues is uncommon in elastin,
crosslinks involving hydroxylysine only occur in collagen (Eyre et al., 1984). In
contrast, the tetra-functional crosslinks, desmosine and isodesmosine, are unique to
elastin and are formed when allysine residues spontaneously condense with other
lysine and allysine residues (section 1.3; Thomas et al., 1963). Despite being
tetra-functional, these crosslinks are believed to join only two chains of elastin
(Rosenbloom et al., 1993).
1.5 Proteoglycans
Proteoglycans are molecules comprised of a protein core covalently linked to one or
more glycosaminoglycan (GAG) chains (for reviews see Gallagher, 1989; Kjellan
and Lindahl, 1991). Glycosaminoglycans are long, unbranched polysaccharide chains
comprised of repeating disaccharide units. In general, the disaccharide contains a
derivative of an amino sugar (either D-glucosamine or D-galactosamine) and either
hexuronic acid (D-glucuronic or L-iduronic acid) or galactose units. At least one of
these sugars is modified with the addition of sulphate or carboxylate groups to give a
net negative charge to the molecule. GAG chains can be classified according to the
structure of their repeating disaccharide backbone as hyaluronic acid (HA), the
galactosaminoglycans chondroitin sulphate (CS) and dermatan sulphate (DS) and the
glucosaminoglycans keratan sulphate (KS), heparin and heparan sulphate (HS;
Roden, 1980; Wight et al., 1991). Hyaluronic acid, also known as hyaluronate or
hyaluronan, is unique amongst GAGs in that it is not covalently bound to a protein
core. It is present as extensive anionic polymers and it assumes a stiff, randomly
kinked, coil structure which is able to form networks with itself and, via
non-covalent interactions, with a number of other matrix macromolecules (for
example in cartilage; Rosenberg et al., 1975; Kjellan and Lindahl, 1991).
As well as large variations in the length, composition and number of GAG chains,
there are also large variations in the nature of the protein core. Thus, the definition of
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a proteoglycan encompasses a large number of molecules with diverse structures,
functions and localisation. In general, proteoglycans can be classified in terms of
their localisation into extracellular, intracellular and membrane bound proteoglycans
(Iozzo and Murdoch, 1996).
1.5.1 Extracellular proteoglycans
The extracellular proteoglycans can be divided into small leucine rich proteoglycans
(SLRP) and modular proteoglycans (for review see Iozzo and Murdoch, 1996). The
SLRP family consists of the DS/CS proteoglycans decorin, biglycan and epiphycan
and the KS proteoglycans fibromodulin and lumican (Krusius and Ruoslahti, 1986;
Fisher et al., 1989; Shinomura and Kimata, 1992; Oldberg et al., 1989; Blockberger
et al., 1992). As the name suggests these proteins are characterised by a large central
domain containing a number of 24 amino acid long, leucine-rich repeats (LRR)
which is flanked on either side by highly conserved cysteine-rich regions. The
attachment sites for GAG chains are found within this central region in fibromodulin
and lumican (Plaas et al., 1990; Blockberger et al., 1992) and within the N-terminal
region for decorin, biglycan and epiphycan (Chopra et al., 1985; Fisher et al., 1989;
Shinomura and Kimata, 1992; Figure 1.3). Decorin and biglycan also have N-linked
glycosylation sites within the leucine-rich repeats and in fibromodulin and lumican
the N-terminal region contains sites for tyrosine sulphation (Antonsson et. al., 1991;
Blockberger et al., 1992). The SRLPs appear to be multifunctional molecules with
potential roles in regulation of collagen fibrillogenesis and the supramolecular
organisation of the ECM (Table 1.2; section 1.7), inhibition of cell attachment and
regulation of cell growth (Iozzo and Murdoch, 1996). For example, in addition to the
role of decorin in fibrillogenesis (section 1.7) it also binds to fibronectin and inhibits
fibronectin-mediated cell adhesion (Lewandowska et al., 1987) and binds to and
inhibits the activity of the growth factor TGF-(3. Additionally, TGF-(3 stimulates the
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Figure 1.3. Schematic diagram of the structure of decorin and its interaction
with collagen monomers and fibrils, (a) Binding domains of decorin; rectangles
represent leucine rich repeats ,— represents GAG chain and Y represents
N-glycosylation sites; Putative binding sites for fibronectin (FN), thrombospondin
(TSP), collagen I (coll I) and glycosaminoglycans (GAGs) are indicated.
C represents cysteine residues. The leucine-rich repeats give rise to the three-
dimensional horseshoe structure of decorin seen in cross section in (b). Circles
represent collagen monomers. Decorin is believed to interact with two monomers,
one within the arch of the horseshoe and another via the C-terminal arm. This would
allow the monomers to be correctly orientated in the quarter staggered array within
the growing fibril (b,c). From Kresse et al., 1993; Iozzo and Murdoch, 1996; Weber
et al., 1996.
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The modular proteoglycans have less sequence homology than the SRLPs but are
grouped together since they are comprised of various protein modules in a relatively
elongated and often highly glycosylated structure. They can be further sub-divided
into the hyalectins and the non-hyaluronan binding proteoglycans (Iozzo and
Murdoch, 1996). The hyalectin family includes aggrecan, versican, neurocan and
brevican and contains an amino terminal domain with hyaluronan binding properties,
an extended central domain with GAG binding sites and a carboxyl terminal domain
with homology to the selectin family (Doege et al., 1987, 1991; Zimmerman and
Ruoslahti, 1989; Rauch et al., 1992; Yamada et al., 1994). The most well studied of
the hyalectins is the cartilage proteoglycan, aggrecan. It is able to form large
supramolecular aggregates with hyaluronan (section 1.5) through its amino terminal
domain and has a large number of GAG chains attached to the central domain. Thus,
aggrecan has a high charge density resulting in a large hydrodynamic volume and the
ability to withstand compressive forces (Gallagher, 1989). The hyalectins are also
believed to function as a bridge between cells and the ECM, with the hyaluronan
binding domain interacting with the hyaluronan surface coat of some cells and the
lectin-like domain interacting with carbohydrate moieties on various ECM molecules
(Iozzo and Murdoch, 1996). Perlecan, agrin and testican make up the non-hyaluronan
binding family of proteoglycans (Noonan et al., 1991; Tsen et al., 1995; Alliel et al.,
1993). Perlecan is the major HS proteoglycan of basement membranes with potential
roles in maintaining a negatively charged barrier, cell adhesion / anti-adhesion and
regulation of cell growth by binding to released growth factors and cytokines and
sequestering their effect (Iozzo et al., 1994).
1.5.2 Intracellular and membrane bound proteoglycans
The small proteoglycan, serglycin is found intracellularly within secretory vesicles
and the core protein contains extended sequences of repeating serine and glycine
residues (Avraham et al., 1988; Seldin et al., 1985). These serine-glycine residues
represent GAG attachment sites and provide the potential for a highly glycosylated
and thus negatively charged molecule. Serglycin is proposed to have roles not only
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relating to its polyanionic nature (e.g. reduction of osmotic pressure) but also in
binding proteases within vesicles thus modulating their activity (Kresse et al., 1993).
Membrane bound proteoglycans also exist which associate covalently with the
phospholipid bilayer either via a transmembrane domain within the protein core (e.g.
syndecan) or a phosphatidyl inositol membrane anchor, or non-covalently through
proteoglycan or GAG cell surface receptors (e.g. hyaluronan; for review see
Gallagher, 1989).
1.6 Tyrosine rich acidic matrix protein (TRAMP)
In addition to the four major classes of macromolecule found in the ECM (i.e.
collagens, elastin, proteoglycans and glycoproteins), a number of less well
characterised, low molecular weight proteins are present. One such protein is
Tyrosine-Rich Acidic Matrix Protein (TRAMP) which was originally identified as
the major contaminant in preparations of lysyl oxidase from porcine skin (Shackleton
and Hulmes, 1990a). Subsequent purification and amino acid sequencing of this
protein showed it to be unrelated to lysyl oxidase but identical to bovine 22K ECM
protein (Cronshaw et al., 1993; Neame et al. 1989). The human equivalent,
dermatopontin, was later identified as a contaminant in preparations of proteoglycans
from human fibroblast cultures and cDNA sequencing showed it to have 96%
homology to the bovine form (Superti-Furga et al., 1993).
1.6.1 Structure of TRAMP
The amino acid sequence of TRAMP is characterised by a high percentage of
tyrosine residues (9.7%), no N-glycosylation sites and three homologous domains
characterised by the presence of positively charged residues and a central hexapeptide
motif (i.e. Asp-Arg-Glx-Trp-Asn/Gln/Lys-Phe/Tyr; Cronshaw et al., 1993). Five
32 59 121 178 72
disulphide bonds have been identified between Cys -Cys" , Cys -Cys , Cys -
Cys"4, Cys88-Cys"5 and Cys125-Cys171. It has been suggested that the arrangement of
disulphide bridges within TRAMP would place one of the hexapeptide repeats in
each of three loop structures which would allow interactions between these motifs
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and other ECM molecules (Neame et al., 1989). Additionally, an 18 amino acid,
N-terminal signal sequence is present within the cDNA sequence of dermatopontin
(Superti-Furga et al., 1993). Analysis for hydrophobicity showed the protein to be
very hydrophilic except for two regions of strong hydrophobicity around residues 40
and 90. Secondary structure prediction using the method of Chou and Fasman
showed no overall tendency for either (3-sheet or a-helix, although this has yet to be
confirmed by circular dichroism (Neame et al., 1989).
1.6.2 Tyrosine sulphation of TRAMP
Five charge variants of TRAMP have been identified, separable by Mono Q anion
exchange FPFC (Cronshaw et al., 1993). Their pi values vary from 4.43 to 4.07 and
their molecular masses from 22,119 to 22,352 daltons. Evidence suggests that the
variants are the result of different patterns of tyrosine sulphation within the protein.
Tyrosines 5, 15, 148, 149 and 176 fit the empirically determined rules for tyrosine
sulphation involving the proximity of acidic residues and relative paucity of basic
residues, hydrophobic residues and cysteine (Hortin et al., 1986; Cronshaw et al.,
1993). In addition, TRAMP can be visualised on SDS-PAGE gels by Alcian blue
staining and this staining, relative to Coomassie staining is decreased if the protein is
subjected to acid hydrolysis or sulphatase treatment (Cronshaw et al., 1993). Finally,
35S-labelled TRAMP is synthesised by human foreskin fibroblasts cultured in the
presence of [35S]-sulphate and alkaline hydrolysis followed by amino acid analysis
has confirmed that the radiolabeled sulphate is incorporated into sulfotyrosine
(Forbes et al., 1994).
Tyrosine sulphation is a widespread post-translational modification and in addition to
TRAMP, a number of other ECM proteins are modified in this way. These include
fibromodulin, procollagens III and V, fibronectin, vitronectin, osteopontin (BSPII)
and entactin (Antonsson et al., 1991; Jukkola et al., 1986; Fessler et al., 1986; Paul
and Hynes, 1984; Jenne et al., 1989; Ecarot-Charrier et al., 1989; Paulsson et al.,
1985). The significance of tyrosine sulphation remains to be elucidated. Since the
majority of tyrosine sulphated proteins identified to date are secreted, it has been
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postulated that tyrosine sulphation may play a role in the secretory mechanism
(Huttner, 1988). However, inhibition of tyrosine sulphation by chlorate had no effect
on the synthesis or secretion of procollagen III from human skin fibroblasts (Jukkola
et al., 1990). Alternatively, it has been suggested that the increase in negative charge
which accompanies incorporation of sulphate into a protein may influence
subsequent interactions of that protein. For example, partial removal of sulphate
groups from fibronectin results in a decrease in the fibrin binding activity (Suiko and
Lui, 1988).
1.6.3 Tissue distribution of TRAMP
Western blot analysis of TRAMP show it to be a widely distributed protein in
porcine and murine tissue. Positive results were observed for skin, cartilage, long
bone, calvaria, skeletal muscle, lung, heart and kidney with no detectable TRAMP in
liver, brain or spleen (Forbes et al. 1994). This is consistent with the expression of
dermatopontin in human tissues analysed by Northern blotting, where expression was
also observed in pancreas (Superti-Furga et al. 1993). Dermatopontin has been
further localised, with antibodies to the bovine form of TRAMP, both around
collagen fibres and unexpectedly within dermal endothelial cells in human skin
biopsies (Okamoto et al., 1996).
1.6.4 The biological function of TRAMP
The biological function of TRAMP is still unclear, although evidence to date
suggests a number of possibilities:-
1.6.4.1 Attachment of cells to the extracellular matrix.
The bovine form of TRAMP (22K) has been shown to promote cell adhesion of
mouse Balb/c 3T3 cells, human and bovine dermal fibroblasts, human Piatt
neuroblastoma cells and F11 hybrid neuronal cells, when absorbed onto tissue culture
cluster dishes (Lewandowska et al., 1991). Approximately 25% of 3T3 cells attach
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stably, representing 35-40% of the levels of plasma fibronectin (pFN) mediated
attachment. Phase contrast and scanning electron microscopy showed that cells
undergo attachment and spreading on 22K substrata but no more extensive
cytoskeletal reorganisation is evident. It was postulated that the cell surface receptor
for 22K was an integrin since cell attachment to the substrata was inhibited by the
addition of a Gly-Arg-Gly-Asp-Ser-Pro-Cys (GRGDSPC) peptide (section 1.8). Also,
22K contains the putative integrin binding site RGAT (Hautanen et al., 1989;
Ruoslahti, 1987; Ruoslahti and Pierschbacher, 1987; Yamada and Kennedy, 1987).
Since pre-treatment of the cells with chondroitinase ABC had no effect on cell
attachment, the possibility that the receptor was a cell surface DS proteoglycan seems
unlikely. Cell attachment of 22K was inhibited by decorin (Lewandowska et al.,
1991; section 1.5.1).
1.6.4.2 Regulation of collagen I fibril assembly
Macbeath et al. (1993) showed that TRAMP accelerates collagen I fibril formation in
vitro using the 'warm start' technique (Holmes et al., 1986; section 1.7.1). The effect
was characterised by a decrease in the lag phase and an increase in both the growth
rate and the final turbidity (Figure 1.4). Acceleration was still observed at
sub-stiochiometric ratios of TRAMP to collagen (i.e. molar ratios of 1:20) suggesting
the possibility that TRAMP acts on the early nucleation phase of fibrillogenesis. It
was also observed that TRAMP partially reversed the inhibitory effects of increased
ionic strength and urea but not of glucose. Since glucose is believed to inhibit
fibrillogenesis by interacting with the non-helical telopeptides of collagen it is
possible that TRAMP also interacts with them. However, TRAMP also accelerates
fibrillogenesis of pepsinised collagen I and thus it may interact with collagen
monomers at more than one site. The presence of TRAMP stabilises collagen fibrils
against dissociation when the temperature is dropped to 4°C and also results in a
decrease in fibril diameter. All TRAMP variants are equally effective at accelerating
fibril formation (Macbeath et al., 1993).
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The bovine form of TRAMP has recently been shown to interact with the protein
core of the dermatan sulphate proteoglycan, decorin (section 1.5.1; Okamoto et al.
1996). The interaction is disrupted by guanidine hydrochloride but not by cleavage of
the disulphide bonds present in either decorin or 22K. The significance of this
interaction is unclear but since decorin is known to inhibit collagen fibrillogenesis in
vitro (Vogel et al., 1984; section 1.7.3) it is plausible that TRAMP and decorin work
together to regulate the deposition of collagen in the ECM. Additionally, since
TRAMP appears to have cell adhesion activity it may also have a role in the cellular
control of fibril deposition (section 1.7.4).
1.6.4.3 Crosslinking of collagen
TRAMP contains the putative topaquinone incorporation consensus sequence
Asn-Tyr-Asp, which is associated with a number of copper dependent amine
oxidases (Mu et al., 1992; section 1.4.5). Additionally, preliminary investigations
showed that after incubation of TRAMP with [4,5-3H] lysine labelled collagen I at
37°C overnight followed by SDS-PAGE analysis, an increase in the Pi,2 components
was observed (Forbes, unpublished observations). Since the (31,2 components
correspond to dimers of a chains this suggested that intramolecular crosslinks were
formed. These observations together with the ability of TRAMP to stabilise collagen
fibrils against low temperature dissociation (Macbeath et al., 1993; section 1.6.4.2)
have led to the suggestion that TRAMP may act as a collagen specific lysyl oxidase.
1.7 Collagen fibril assembly
Matrix assembly occurs not only during growth and development of an organism but
also during repair and regeneration (for review see Birk et al., 1991). The assembly
of the matrix is a complex process involving many interactions between adjacent
matrix molecules and between matrix molecules and the cell. Fibrillar collagens are
the major components of most connective tissues and thus the physical properties of
tissues are determined to a large extent by the three-dimensional organisation of
collagen fibrils. Since the various collagen types have very different supramolecular
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structures, matrix assembly is dictated by the tissue specific expression of unique
collagen types. However, tissues which produce the same collagen type can have very
different structures and thus additional controls on matrix assembly must occur. The
assembly and correct spatial arrangement of collagen fibrils is affected by other
matrix components such as proteoglycans. In addition, the assembly process is
controlled at the cellular level via integrin and non-integrin receptors. Since the
major step in matrix assembly is formation of collagen fibrils, the following section
will concentrate on collagen fibrillogenesis and in particular the assembly of collagen
I fibrils (for review see Kadler et al., 1996).
1.7.1 Collagen fibril assembly in vitro
Solutions of extracted collagen in neutral buffers have long been known to aggregate
spontaneously into fibrils when the temperature is raised (Wood and Keech, 1960).
The characteristic turbidity-time curve obtained by spectrophotometric analysis of the
assembly process is triphasic. First there is a lag phase due to the time it takes to
produce fibrils of sufficient size to be detected by scattering of light. This is followed
by a period of rapid growth and finally, when fibril assembly is complete, a plateau
region (Figure 1.4; Gross and Kirk, 1958; Williams et al., 1978).
Until recently, the most common method used to initiate fibril formation was the
'cold-start' technique whereby cold acidic solutions of collagen are first mixed with
an equal volume of double strength neutralising buffer before raising the temperature
(Williams et al., 1978). To eliminate problems caused by precipitation after
neutralisation in cold conditions, the 'warm-start' technique was developed (Helseth
and Veis, 1981). In this procedure, both collagen and neutralising solutions are first
warmed to the desired temperature and are then mixed to initiate fibril assembly
(Holmes et al., 1986). However, difficulties also arise from this method due to
variations in assembly rate caused by mixing and stirring currents. Thus, both these
methods require strict controls for reproducible results to be obtained. An alternative
method to study fibril assembly and growth was described by Kadler et al. (1987). In
this procedure fibril assembly is initiated by specific enzymatic cleavage of the
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Figure 1.4. Typical turbidity-time curve for collagen I fibril assembly in
vitro. The lag time (tlag ), maximum turbidity and time to half maximum
turbidity (tl/2) are marked by arrows. Additionally, the rate of growth during
the growth phase can be calculated from the gradient of the line.
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C-propeptide from pC-collagen (a soluble precursor, lacking the N-propeptide) using
C-proteinase/BMP-1.
1.7.2 Possible mechanisms of collagen fibril assembly
The ability of fibril-forming collagens to self-assemble in vitro suggests that the
assembly process is controlled largely by the amino acid sequence of collagen and the
distribution of polar and hydrophobic residues (Veis and George, 1994; Prockop and
Kivirrikko, 1995). Evidence also exists for initiation of fibril assembly by
conformational changes within the monomer which 'perfect' the triple helix (George
and Veis, 1990, 1991). The mechanism of assembly remains unclear although two
main hypotheses exist to explain the kinetics observed in vitro. One theory is based
on a nucleation-growth process where the rate-limiting step is the formation of an
initial aggregate or nucleus onto which monomers can rapidly add to form the final
D-periodic fibril. The second theory suggests an intermediate-assembly process
whereby small intermediate aggregates form during the lag phase which can then add
to each other to form a fibril (Veis and George, 1994). Electron microscopy and light
scattering studies on collagen solutions at various stages of the assembly process
have led to contradictory observations offering support for both these theories. Some
workers have identified 4D staggered dimers and trimers early in the lag phase which
then appear to aggregate linearly (Trelstad and Hayashi, 1976; Silver and Trelstad,
1979; Gelman and Piez, 1980; Silver, 1981; Kadler and Chapman, 1985; Ward et al.,
1986). Other workers have been unable to see such species and thus observe the long
thin intermediate subassemblies or 'early' fibrils as the first formed aggregates
(Gelman et al., 1979; Payne et al., 1986; Na et al., 1986). The conflicting results may
be explained by the observation that the method used to initiate fibril formation
affects the route of assembly and thus the nature of aggregates formed (Holmes et al.,
1986). Also, identification of the first formed aggregates in the pathway is hampered
by the low concentrations of such species present and by the production of artefactual
aggregates (Kadler et al., 1996).
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Further understanding of the mechanism of assembly can be gained by studying the
differences in kinetics observed from collagen solutions obtained by different
purification methods. The presence of a high percentage of crosslinked oligomers
results in a decrease in the lag phase compared to preparations of purely monomeric
collagen suggesting that the oligomers already contain the nucleation centres and thus
supporting a nucleation growth process (Na et al., 1986). Pepsin-treatment of
collagen increases the lag phase suggesting a role for the N-and C-non-helical
telopeptide regions in the nucleation phase (Helseth and Veis, 1981).
As mentioned above, 'early' fibrils have been identified during the initial stages of
fibril assembly and in particular towards the end of the lag phase. These are usually
banded (depending on the initiation procedure) and between 1 and 20pm in length
(Holmes et al., 1986). The development of the cell free system for studying fibril
formation (section 1.7.1) allowed for further study of these 'early fibrils' since at low
temperatures (29-32°C) the diameters of the fibrils are sufficiently large to be
visualised by dark field light microscopy and the growth of the fibril can be
monitored by time lapse photography (Kadler et al., 1987, 1988). The earliest
aggregates observed by this method are needle-like with a pointed, paraboloidal a-tip
and a blunt end (Kadler et al., 1990; Holmes et al., 1992). Growth occurs exclusively
from the a-tip unless the temperature and concentration of pC-collagen are raised, at
which point growth also occurs from the blunt end producing a [3-tip. It is thus
suggested that in vivo growth occurs first at the a-tip and later at the blunt end
(Kadler et al., 1990). The shape of the tips appears to be set up early during growth
since it is maintained as growth proceeds (Holmes et al., 1992). Another interesting
observation is that the ratio of C-proteinase to pC-collagen affects the shape of the tip
and symmetry of the fibrils with finer tips and more assymetric fibrils being produced
at low ratios (Holmes et al., 1996). It is unclear how fibril growth occurs although
recently two computer generated models have been devised to try and explain the
observation from the de novo system. The first is a helical model of nucleation and
propagation (Silver et al., 1992) and the second is based on diffusion limited
aggregation of collagen monomers (Parkinson et al., 1995). The former requires very
specific growth rules whilst the latter suggests a more random process. Recent
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observations on fibril segments from chick tendon at various stages of development,
suggest that whilst addition of individual monomers onto the growing fibril may
account for the initial assembly of fibrils, maturation of fibrils involves fusion of
fibril intermediates. (Birk et al., 1995, 1996, 1997).
1.7.3 Parameters affecting the kinetics of fibril assembly
In vitro the rate of fibril assembly is not only dependent on the method used to
initiate the process but also on the composition of the neutralising buffer. The ionic
strength, pH, nature of the micro-ion and dielectric constant all affect the kinetics and
the morphology of fibrils formed (Hayashi and Nagai, 1973a,b; Williams et al., 1978;
Pogany et al., 1994). In addition, the kinetics are sensitive not only to the starting
concentration of collagen but also its composition, source and the method used to
purify it (Veis and George, 1994). For example, the presence of even small traces of
aggregates can substantially decrease the lag phase (Na et al., 1986). The kinetics are
also highly temperature-dependent with an optimal temperature for fibril assembly of
between 34 and 36°C (Williams et al., 1978). The kinetics even appear to be
sensitive to the shape of the reaction vessel used and the mode of heating (Veis and
George, 1994).
Both glycosaminoglycans and proteoglycans have been shown to alter the kinetics of
fibrillogenesis in vitro. In general, GAGs which interact most strongly with collagen
fibrils have the greatest effect on fibrillogenesis. In particular, dermatan sulphate,
heparan sulphate and heparin accelerate the assembly process whilst chondroitin
sulphate, and keratan sulphate have no effect (Scott, 1988). A number of small
leucine-rich proteoglycans have the reverse effect on fibril assembly (Table 1.2).
Decorin, lumican and fibromodulin bind collagen and inhibit the assembly of fibrils
(Vogel et al., 1984; Scott and Haigh, 1985; Rada et al., 1993; Hedbom and
Heinegard, 1989). In contrast, another member of this family, biglycan, has no effect
on fibrillogenesis and only binds to collagen at low phosphate concentrations. It may
be that unlike decorin, fibromodulin and lumican which interact with collagen via
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Table1.3.Summaryofinter ctionsnon-proteoglycancomponentsfthECMwithcoll gI 4*=decrease,'fincrease,V-binding,X=oi i ,?unknown.
(Pogany et al., 1994). It has been observed that both fibromodulin and decorin bind
to collagen monomers at higher molar ratios than to collagen fibrils, suggesting roles
in early nucleation phases of fibril assembly (Hedbom and Heinegard, 1993).
A number of other non-collagenous proteins are known to affect the rate of fibril
assembly in vitro. Inhibitory effects have been observed for fibronectin, dentin
phosphoryn and myelin-associated glycoprotein (MAGP), whilst osteopontin and
TRAMP (section 1.6.4.2) accelerate the assembly process (Kleinman et al., 1981;
Cocking-Johnson and Sauk, 1983; Probstmeier et al., 1992; Macbeath et al., 1993;
Fujisawa and Kuboki, 1992). A number of other components of the ECM including
vitronectin and flexilin have been shown to bind to collagen but their effect, if any on
fibril assembly has yet to be determined (Gebb et al., 1986; Lethias et al., 1996;
Table 1.3).
1.7.4 Control of Fibril Diameter and Growth and Supramolecular Organisation
The diameters of collagen I fibrils vary within the same tissues, among different
tissues and during development. Thus, strict tissue specific controls on fibril diameter
must exist in vivo. A number of factors which appear to regulate fibril diameter,
growth and the supramolecular organisation of fibrils within tissues are discussed
below.
Immunoelectron microscopy has localised the N- and C-propeptides on or near
collagen fibrils in a number of tissues (Fleischmajer et al., 1983, 1985, 1987a,
1987b). It is unclear whether this is due to surface association of cleaved propeptides
or to pN- and pC-collagen intermediates. However, changes in fibril diameter during
development of chick embryos are accompanied by changes in the pN/pC-collagen
ratio (Fleischmajer et al., 1985). Also, the order of cleavage of the propeptides
affects fibril diameter, with thinner fibrils being formed if the C-propeptide is
cleaved first (Fleischmajer et al., 1987b). It has thus been suggested that the
N-propeptide is not cleaved before fibril assembly so that pN-collagen is
incorporated into the growing fibril. The N-propeptide is constrained to the surface of
the growing fibril and eventually becomes tightly packed, limiting the diameter of the
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fibril. Cleavage of the N-propeptide must occur before the fibril can continue to grow
(Kadler et al., 1996). This theory also fits in with the observation in vivo that fibrils
have preferred diameters which are multiples of 1 lnm (Parry and Craig, 1979;
Hulmes, 1983). Additionally, the persistence of the procollagen N-propeptide appears
to affect fibril morphology (Hulmes et al., 1989; Watson et al., 1992)
Electron microscopy studies have also localised a number of proteoglycans, including
decorin and lumican, to collagen fibrils in vivo (Scott, 1980; Scott and Orford, 1981:
Scott and Haigh, 1985). The type of interaction varies from tissue to tissue. In the
corneal stroma and developing tendon, proteoglycans are interfibrillar, bridging one
fibril to another and thus maintaining a stable orientation between neighbouring
collagen fibrils (Doane et al., 1992; Scott, 1993). There is also evidence that
proteoglycans can be intrafibrillar, for example in the collagen II-rich fibrils of costal
cartilage (Scott, 1985). It has been suggested that they may have a role in the
aggregation of 'early fibrils' into larger mature fibrils (Birk et al., 1995).
Proteoglycans have also been shown to be surface-associated, either partly or
completely encircling the fibril and with specific binding sites. In this case, it is
believed that their role is to limit fibril diameter and/or growth (Scott, 1993).
Additionally, certain proteoglycans are able to bind FACIT collagens and collagen VI
as well as fibrillar collagens. They may therefore mediate the interactions between
non-fibrillar collagens and fibrillar collagens (Font et al., 1993, 1996; Keene et al.,
1996). Recent studies on the three-dimensional structure of decorin has suggested a
role in the correct positioning of collagen molecules within the staggered
conformation of the fibril. Rotary shadowing and molecular modelling studies show
decorin to be horseshoe shaped and it is postulated that it binds to one collagen
monomer within the recess and to a second, adjacent monomer via one of the arms of
the horseshoe (Figure 1.3; Weber et al., 1996; Scott, 1996). The importance of
proteoglycans in the regulation of collagen fibril growth was recently highlighted by
observations from mice disrupted at the decorin gene locus. The skin from these mice
was fragile and had reduced tensile strength. In addition, the collagen fibrils were
more loosely packed compared to the skin from normal mice and had variations in
diameters along their shafts (Danielson et al., 1997).
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Most fibrillar collagens are now believed to be heterotypic (Birk and Lisenmayer,
1994). One reason for this is to control fibril diameter. Both collagen III and
pN-collagen III are found associated with type I collagen fibrils in certain tissues
(Fleischmajer et al., 1981, 1983, 1990). pN-collagen III has been shown to form true
copolymers with collagen I after enzymatic cleavage of precursor forms. The fibrils
formed are thinner than fibrils containing collagen I only and the rate of formation of
fibrils is slower. Thus, pN-collagen III may regulate fibril diameter by coating the
surface of the fibril thereby preventing lateral growth but allowing growth from tips
to proceed (Romanic et al., 1991). Recently, the importance of collagen III for
collagen I fibrillogenesis was demonstrated by gene knockout experiments.
Inactivation of the COL3A1 gene in mice resulted in the reduction or absence of
collagen fibrils in many tissues and when present, fibrils had highly variable
diameters (Liu et al., 1997). The diameters of collagen I fibrils also appear to be
regulated by the presence of collagen V. The connective tissue of the corneal stroma
is mostly comprised of collagen I and also contains relatively high amounts of
collagen V. In addition, collagen fibrils within the cornea have a very narrow range
of small-diameters (25nm) to allow for optical transparency. Thus, a relationship
between fibril diameter and collagen V was suggested. Collagens I and V have since
been shown to form heterotypic fibrils and fibrils formed in vitro from mixtures of
these two collagen types have smaller diameters than those formed with collagen I
alone (Birk et al. 1986a, 1990). More recently, Marchant and co-workers (1996)
showed that when the levels of collagen V secreted by chick corneal cells were
reduced using a dominant negative retroviral strategy, the fibrils produced had larger
diameters and a broader size distribution. Members of the FACIT family of collagens
also appear to regulate fibril diameter. Collagen II forms heterotypic fibrils with
collagens IX and XI (Mendler et al., 1989). Collagen XI forms a cylindrical core
around which molecules of collagen II are arranged. Collagen IX is found exclusively
at the surface of the fibril and again may act not only to regulate fibril diameter but
also as a bridge between neighbouring collagen fibrils (Wu et al., 1992).
In addition to various extracellular components, the cell is also believed to play a role
in the regulation of collagen fibril growth and their organisation into supramolecular
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aggregates. Birk et al. (1986b) observed a number of extracellular compartments
within tendon formed by invaginations of the fibroblast plasma membrane. These
compartments could be divided into narrow recesses containing a single collagen
fibril and larger indentations enveloping fibril bundles. Further investigation led to
the suggestion that the initial events of fibril assembly, such as cleavage of the
propeptide and assembly of 'early fibrils', take place in the narrow recesses under
tight cellular control. The recesses then fuse to allow individual fibrils to fuse
laterally and/or longitudinally forming longer/thicker fibrils. Further fusion of these
larger recesses would then allow association of fibrils into bundles (Birk et al.,
1989). In addition to this, a further level of cellular control is suggested by the
observation that vacuoles within cultured fibroblasts and chondrocytes contain
segment-long-spacing (SLS) crystallites (Bruns et al., 1979). Thus, the initial stages
of fibrillogenesis may take place intracellularly.
1.8 Cell-Matrix Interactions
Interactions between the ECM and the cell occur via a number of cell surface
adhesion receptors which include the integrin family (Newham and Humphries,
1996), membrane associated proteoglycans (section 1.5.2; Gallagher, 1989) and the
elastin receptor, which not only binds elastin but also laminin and collagen IV
(Hinek, 1996). Additionally, the recently discovered transmembrane collagens may
also play a role in cell-matrix communication (section 1.2.1; Hopkinson and Jones,
1996).
Integrins are heterodimers, composed of a and [3 subunits. Both the a and (3 subunits
have large extracellular domains, a single transmembrane domain and a short
cytoplasmic domain. The extracellular domain contains binding sites for a number of
ECM ligands including fibronectin, tenascin, thrombospondin, vitronectin, bone
sialoprotein and various collagens (for reviews see Ruoslahti, 1991; Newham and
Humphries, 1996). The integrin recognition sites within these molecules are
generally short peptide sequences (e.g. Arg-Gly-Asp) which are presented in
extended loops containing (3 turns (Humphries, 1990). Binding of ligands activates
33
cell signalling cascades within the cell via Focal Adhesion Kinase (FAK; Richardson
and Parsons, 1995). In addition to this 'outside-in' signalling , integrin activity can
also be modulated from inside the cell (inside-out signalling; O'Toole et al, 1994).
Thus, regulation of the cell by the surrounding matrix and of the matrix by the cell
appears to be a constantly changing subtle process (Newham and Humphries, 1996).
1.9 Aims of project
The initial aim of the project was to produce highly purified, active TRAMP
completely free from contaminating lysyl oxidase. Once purified the interactions of
TRAMP with collagen I monomers and fibrils could be studied using ELISA,
fibrillogenesis and co-sedimentation assays. These methods could also be used to
study the combined effect of TRAMP and decorin on collagen I fibril formation in
vitro and the effect of decorin on the interactions of TRAMP with collagen fibrils
and monomers. An additional aim was to identify binding sites for TRAMP on
collagen fibrils using electron microscopy and immunogold labelling. Further aims of
the project were to investigate the possible amine oxidase activity of TRAMP using
benzylamine, elastin and collagen substrates. Finally, we hoped to study in more






2.1 Lysyl oxidase ultrafiltration assay
2.1.1 Preparation of [3H] elastin substrate
Lathyritic [4,5-'H] lysine labelled elastin was prepared as described previously
(Siegel et al., 1970; Kagan et al., 1979).
2.1.1.1 Materials
Seventeen day old chick embryos were supplied by Ross Breeders, Newbridge,
Midlothian. MEM Select-amine kits were from GIBCO, Paisley, Strathclyde. [3-APN
(fumarate salt) was from Sigma Chemicals Co., Poole, Dorset. Unless otherwise
stated, all other reagents were from BDH, Poole, Dorset.
2.1.1.2 Procedure
Culture media and flasks were sterilised by filtration through 0.22jitm filters and
autoclaving respectively. Thoracic arteries from 10 dozen, 17-day old chick embryos
were dissected and placed into Petri dishes containing MEM Select-amine incubation
medium with 50 units/ml penicillin and 50|lg/ml streptomycin (GIBCO). This
medium lacked lysine but was supplemented with 50mg/l each of glycine, alanine,
valine, proline and ascorbate to increase yields of elastin (Shackleton and Hulmes.,
1990b). Fifty mg/1 of the lathyrogen, (3-aminopropionitrile ((3-APN) was also added
to inhibit endogenous lysyl oxidase activity and the pH was adjusted to 7.4. After
washing in 2 changes of this media the arteries were placed in 300ml fresh medium
in a Nalgene Erlenmayer flask, which was gassed with 5% COi/95% air for 1 minute,
sealed tightly and incubated at 37°C in a model G25 incubator shaker (New
Brunswick Scientific) for 1 hour to deplete lysine. Arteries were transferred to fresh
medium containing 15pCi/ml [4,53H]-lysine, gassed again and incubated overnight at
37°C. The incubation medium was discarded and the arteries were washed in several
changes of cold distilled water. To extract components other than elastin, the arteries
were homogenised in a small volume of 0.15M NaCl in a glass homogeniser,
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transferred to a centrifuge tube and topped up to 50ml with 0.15M NaCl. The
homogenate was then centrifuged at 10,000g for 5 minutes at 4°C. The supernatant
was discarded and the salt extraction step repeated. To inactivate endogenous lysyl
oxidase the pellet was homogenised in 1M hydrochloric acid and centrifuged as
above (Kagan et al., 1979). This step was repeated once. The pellet was then
homogenised in assay buffer (0.1M sodium borate, 0.15M NaCl, pH 8.0) and again
centrifuged as above. After repeating this step once more, the pellet was resuspended
in assay buffer to give a final concentration of labelled elastin of 300,000dpm per
lOOpl The elastin substrate was stored at -30°C and thawed and re-homogenised just
prior to use.
2.1.2 Ultrafiltration assay
Lysyl oxidase activity was measured using a modification of the method of Pinnell
and Martin (1968). Active lysyl oxidase will convert the £-amino groups at the 6
position of [4,5-'H] labelled lysine residues on elastin to allysine (Figure 1.2).
Allysine then undergoes keto-enol tautomerism resulting in the exchange of a tritium
atom from the 5 position to the aqueous environment. The tritiated water produced is
then isolated by ultrafiltration through Millipore MC filter units with a 5kDa cut off.
Use of a (3-APN control ensures specificity of the assay (Shackleton and Hulmes,
1990b).
2.1.2.1 Procedure
A total of lOOpl of freshly homogenised elastin substrate was added to a 1.5ml
eppendorf tube and diluted with 700|ll assay buffer. One hundred pi of the sample to
be assayed was then added, mixed by vortexing and incubated at 37°C for 20 hours.
The reaction was stopped by placing tubes on ice and lOOjll of 50% (w/v)
trichloroacetic acid was added to precipitate high molecular weight, tritium labelled
protein. After incubating on ice for 15 minutes, the tubes were centrifuged at 15,600g
for 5 minutes. A total of 420pl of the supernatant was removed, placed in a Millipore
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Ultrafree-MC filter unit (5kDa cut off) and centrifuged at 5,000g for 120 minutes at
4°C in a Beckman JA18.1 rotor. After this, 300pl of the filtrate was removed, added
to 2.7ml Ultima Gold liquid scintillation cocktail (Packard) and 'H cpm were
determined using a Packard 1900 CA liquid scintillation analyzer. For each sample
assayed, control tubes were set up containing the same components but with the
addition of 0.2mM (3-APN to inhibit lysyl oxidase activity. Where possible all
reactions were carried out in duplicate.
2.2 Purification of collagen I monomers
2.2.1 Materials
Male Sprague-Dawley rats were supplied by Banton and Kingman, Universal Ltd,
Field Station, Grimston, Hull. PMSF, NEM and (3-APN (fumarate salt) were
obtained from Sigma (Poole, Dorset). DEAE-Sephacel was supplied by
Pharmacia/LKB (Milton Keynes, Bucks). Unless otherwise stated, all other reagents
(analytical grade) were supplied by BDH (Poole, Dorset).
2.2.2 Procedure
The method was a modification of that of Macbeath et al. (1993) based on that of
Payne et al. (1986). All procedures were carried out at 4°C and in the early stages of
the purification, buffers contained a cocktail of protease inhibitors (25mM EDTA,
ImM PMSF, lOmM NEM and l|lg/ml pepstatin), together with 50jig/ml [3-APN and
0.01% (w/v) sodium azide.
Twelve 21 day old male Sprague-Dawley rats were fed on a diet of rat chow and
water. The water contained 0.17% (w/v) (3-aminopropionitrile ((3-APN), a lathyrogen
which irreversibly inhibits lysyl oxidase activity and thus the crosslinking of
collagen. This in turn increases the extractability of native collagen monomers. After
3 weeks on this diet the rats were sacrificed, shaved and the skins were removed. The
skins (700g) were then cut into small pieces, passed through a pre-chilled mincer and
homogenised at 2ml/g wet weight tissue in 1.08mM Na2HPO.;, 0.22mM KH2PO4, pH
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7.4 in a Waring blender at high speed for 30 seconds. The mixture was centrifuged
for 30 minutes at 10,000g and the pellet was re-homogenised and centrifuged before
extraction overnight (16 hours) in 2ml/g 150mM NaCl, 5.4mM Na2HPC>4, 1.1 mM
KH2P04, pH 7.4.
After centrifugation, the supernatant was passed through 3 layers of cheesecloth to
remove fatty material and further clarified by centrifuging at 18,000g for 2 hours.
The supernatant was retained and solid NaCl was slowly added with stirring to give a
final concentration of 2M. The mixture was left overnight to allow a precipitate to
form. Collagen III precipitates out of neutral solutions at 2M NaCl (Epstein, 1974).
The precipitate was pelleted by centrifugation at 10,000g for 30mins. To isolate
collagen I from other contaminants, the supernatant was subjected to a further salt
precipitation with the addition of solid NaCl up to a final concentration of 3.5M. The
solution was again left overnight to allow a precipitate to form and centrifuged as
before, after which the supernatant was discarded. The pellet was gently
homogenised in a glass/Teflon homogeniser with a small volume of phosphate buffer
(62mM Na2HPC>4, 14.5mM KH2P04, pH 7.4) and then redissolved in a larger volume
of this buffer overnight. Insoluble material was removed by centrifugation at 65,000g
for 4 hours at 4°C.
A second 3.5M NaCl salt precipitation was carried out as described previously and
the precipitate was redissolved in and dialysed against 2 changes of DEAE start
buffer (0.2M NaCl, 50mM Tris-HCl, pH 7.5). The extract was clarified by
centrifuging at 10,000g for 30 minutes before loading onto a DEAE Sephacel anion
exchange column (2.6 x 20cm) at a flow rate of 30ml/ hour. Under these conditions
acidic contaminants such as proteoglycans are retained whilst collagen passes straight
through the column. The absorbance of the unbound fractions were monitored using
a two channel 276nm UV detector (Uvicord) and chart recorder. After sample
loading was complete the column was washed through with DEAE start buffer until
no further UV absorbing material was eluted.
The collagen solution was dialysed exhaustively against 0.02M Na2HPC>4 until a
white precipitate formed, followed by centrifugation at 10,000g for 30 minutes. The
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pellet was redissolved in 0.5M acetic acid overnight and dialysed against the same
solution. A further salt precipitation was then carried out to remove high molecular
weight aggregates (Chandrakasen et al., 1976), with the drop-wise addition of 20%
(w/v) NaCl to a final concentration of 3.5% (w/v). After 15 minutes the resulting
precipitate was centrifuged as above and the supernatant dialysed against two
changes of 0.5M acetic acid followed by 4 changes of 5mM acetic acid. Finally the
solution was centrifuged at 300,000g for 1 hour to produce a clear solution of
collagen I which was stored in 0.5ml aliquots at -70°C and re-centrifuged just prior to
use.
The purity of the collagen solution and its suitability for fibrillogenesis experiments
was assessed by discontinuous SDS-PAGE in reducing and non-reducing conditions
on 6% (w/v) acrylamide separating gels with 4% (w/v) stacking gels (section 2.3).
2.3 SDS-PAGE
2.3.1 Procedure
The method first described by Laemmli (1970) was used for discontinuous
SDS-PAGE of proteins. For separation of proteins with molecular weights in the
range lOOkDato 15kDa, 12% (w/v) acrylamide/0.32% (w/v) bisacrylamide
separating gels were prepared and, for those in the range 200kDa to 60kDa, 6% (w/v)
acrylamide/0.32% (w/v) bisacrylamide separating gels were used. For detailed
procedures for preparation of gels, samples and electrophoresis see Hames (1990).
For SDS-PAGE under reducing conditions samples contained 3% (v/v)
(3-mercaptoethanol whilst under non-reducing conditions samples did not contain
(3-mercaptoethanol. Electrophoresis was carried out in a water cooled LKB vertical
gel electrophoresis apparatus at a constant current of 45mA per gel, with an LKB
2002 power supply. The gels were run for 3 hours or until the tracking dye front was
lcm from the bottom of the gel. Gels were then fixed and stained or taken for
western blotting. When high resolution was not required, mini-gels were run on an
LKB midget electrophoresis unit with water cooling, with run times and
staining/destaining times correspondingly decreased.
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2.3.2 Gel Staining Methods
2.3.2.1 Coomassie blue staining
To visualise protein bands, gels were fixed and stained with 0.25% (w/v) Coomassie
Brilliant Blue R-250, 45% (v/v) methanol, 10% (v/v) acetic acid for 15 to 20 hours
shaking slowly on a Denley reciprocal shaker. The gel was then destained with
several changes of 7.5% (v/v) acetic acid, 5% (v/v) ethanol over 12 hours. The
destaining process could be speeded up by heating the destaining solution to 50°C.
2.3.2.2 Silver Staining
Coomassie blue staining is a relatively insensitive staining method, the lower limit of
detection being 0.2 - 0.5 jig protein (Hames, 1990). For detection of smaller amounts
of protein, silver staining was used. The method was adapted from Morrissey (1981).
Gels were fixed in 45% (v/v) methanol, 10% (v/v) acetic acid overnight, washed in
distilled water for 1 hour and then incubated in distilled water containing 5pg/ml
dithiothreitol for 2 hours to reduce proteins in the gel. This solution was removed and
the gel was incubated for a further 2 hours in 0.1% (w/v) silver nitrate. After washing
with distilled water, the gel was developed in 200ml of 3% (w/v) sodium carbonate
containing lOOpl of 40% formaldehyde until the desired level of staining was
reached. The reaction was then stopped with the addition of 10ml 2.3M citric acid.
After approximately 30 minutes the gel was placed in 2% (v/v) glycerol prior to
photography or drying down.
2.3.2.3 Alcian Blue staining
Alcian blue 8-GX is a cationic dye which stains polyionic groups such as the
negatively charged glycosaminoglycan (GAG) chains of proteoglycans (Scott, 1985).
Macbeath et al. (1993) showed that TRAMP can also be stained with Alcian Blue.
This is probably due to the interaction of the dye with the sulphate groups within
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TRAMP since in 50mM MgCL, Alcian Blue is relatively specific for sulphated
biopolymers (Scott, 1973).
For Alcian Blue staining after SDS-PAGE the method of Wall and Gyi (1988) was
used. Gels were fixed for 1 hour in 50% (v/v) methanol, 7% (v/v) acetic acid and
washed in distilled water for 1 hour. This cycle was repeated once and the gel was
then stained with 0.2% (w/v) Alcian Blue 8-GX, 3% (v/v) acetic acid, 0.05M MgCL
overnight. Destaining was carried out in several changes of 3% (v/v) acetic acid,
0.05M MgCL. Addition ofMgCL prevents the high levels of background staining
usually observed for Alcian Blue.
2.4 Western blotting
Electrophoretic blotting and immunological detection of proteins was performed
using the method first described by Towbin et al. (1979).
2.4.1 Transfer of proteins to nitrocellulose
2.4.1.2 Electrophoretic transfer
Immediately following SDS-PAGE, the gel was removed from the glass plates,
marked uniquely by removing the bottom right hand corner and placed in blotting
buffer (20mM Na2HP04, 20% (v/v) methanol, pH 9.4) for 1-2 minutes. A
gel-nitrocellulose 'sandwich' was then assembled as follows, making sure there were
no air bubbles. The open clamp assembly of a Biorad TRANS-BLOT cell was placed
in a basin of blotting buffer with a scotch-brite pad, followed by a piece of 3MM
Whatman filter paper cut to the size of the gel, then the gel itself and then a piece of
pre-soaked 0.2pm nitrocellulose membrane (Sartorius) of the same size with the
bottom right hand corner removed and finally a second piece of 3MM Whatman filter
paper and a second scotch-brite pad. The clamp assembly was then closed and placed
into the transfer tank containing blotting buffer with the gel side of the sandwich
nearest the negative electrode. The transfer of proteins from the gel to the
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nitrocellulose was completed by running the apparatus for 16 hours at 250mA with
maximum voltage set to 20V.
2.4.1.2 Dot blotting
Where speed rather than sensitivity was the priority, the dot blotting procedure
(Hawkes, 1986) described below was carried out. The base of the BIO-DOT
microfiltration unit (Biorad) was filled with dH20 and the tap was opened briefly to
ensure the tubing was also filled. The centre of the blotter was placed into the base
and the silicon rubber gasket was then placed on top of this assembly. The
nitrocellulose membrane (12.5 x 9.5cm) which had been presoaked in dH20 was then
placed on top of the gasket before replacing the top of the apparatus and tightening
the screws. One hundred pi of the samples to be tested were added to the appropriate
wells and empty wells were filled with an equal volume of dH20. The tap was then
opened and the apparatus was slowly drained. A vacuum was applied to the dot
blotter for 1 minute before closing the tap and slowly releasing the vacuum. Finally,
the nitrocellulose was removed and proteins were detected as described below.
2.4.2 Detection of proteins by enhanced chemiluminescence (ECL)
To check that proteins had been transferred to the nitrocellulose, the membrane was
soaked in 0.4% (w/v) Ponceau S in 3% (w/v) TCA for 1 minute and then washed
with several changes of dH20 to visualise protein bands. The membrane was blocked
with 5% (w/v) dried milk in TBST (50mM Tris-HCl, 0.15M NaCl, 0.05% (v/v)
Tween-20, pH 7.9) for 1 hour with shaking and washed in TBST for 1x15 minutes
followed by 2 x 5 minutes. The primary antibody diluted with TBST was incubated
with the membrane for 90 minutes with shaking. The washing step was repeated
before addition of a 1:5000 dilution of horseradish peroxidase conjugated anti-rabbit
IgG second antibody (SAPU) for a further hour. The washing step was again repeated
before antigen detection with Amersham ECL reagents mixed in a 1:1 ratio and
incubated with the membrane for exactly 1 minute. The membrane was then placed
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onto a piece ofWhatman 3MM filter paper, covered with cling film, placed in a
Kodak X-Omatic cassette and immediately exposed to Kodak X-OMAT AR
scientific imaging film for up to 15 minutes, depending on amount of antigen being
detected and dilution of the primary antibody. All procedures were carried out at
room temperature.
2.4.3 Stripping nitrocellulose membranes
When necessary blots could be stripped and reprobed using a modification of the
method of Kaufman et cil. (1987). The membrane was submerged in stripping buffer
(lOOmM (3-mercaptoethanol, 2% (w/v) SDS, 62.5mM Tris-HCl, pH 6.7) and
incubated at 50°C for 30 minutes. The membrane was then washed in TBST for 1 x
15 minutes, 1x10 minutes and 1 x 5 minutes before repeating western blotting
procedure with the new primary antibody.
2.5 Densitometry
To quantify the results of SDS-PAGE separations, stained gels were scanned using a
Joyce-Loebl Chromoscan 3 coupled to a DCS microcomputer for digital analysis.
The chromoscan was operated in absorbance mode with an aperture of 0.3 x 5mm.
The light source was a 100 W tungsten halogen lamp and scans were carried out with
a red (626nm) filter for Coomassie blue stained gels and a green (530nm) filter for
Alcian blue stained gels. Before calculating the integrated peak areas, a background
subtraction was made.
2.6 Protein assays
2.6.1 Bicinchoninic acid (BCA) protein assay
Protein concentrations were measured using the BCA protein assay (Pierce). This
method, first described by Smith et al. (1985), combines the ability of proteins to
reduce Cu2+ to Cul+ in alkaline conditions, with BCA, a detection reagent for Cul+.
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2.6.1.1 Procedure
The microtiter plate protocol (Redinbaugh and Turley, 1986) was used with standards
in the range 0 to 250pg/ml BSA. All samples were run in duplicate. Working reagent
was prepared by mixing 50 parts solution A containing the BCA detection reagent
with 1 part solution B (4% copper sulphate). Ten pi of each standard, blank or
sample was placed in the appropriate microtiter plate well and 200pl of the working
reagent was added using a digital multi-channel pipette (Labsystems). The plate was
then covered and incubated at 60°C for 30 minutes. After cooling to room
temperature the absorbance at 490nm was measured in a Dynatech MR7000
microplate reader. Protein concentrations of unknown samples were calculated
automatically from the standard curve of varying BSA concentrations using Dynatech
Data Reduction software.
2.6.2 Measurements of collagen concentration
2.6.2.1 Sircol collagen assay
Collagen concentrations were measured using the Sircol collagen assay (Biocolor).
This is a quantitative dye binding assay based on Sirius red. The sulphonic acid side
chain groups on Sirius red react with the side chain groups of the basic amino acids
in collagen. It is believed that the specific affinity of the dye for collagen is due to the
elongated dye molecules becoming aligned with the triple helical structure of
collagen (Junqueira et al., 1979).
2.6.2.1.1 Procedure
Standards were prepared in duplicate from a Img/ml stock solution of collagen I in
0.5M acetic acid (Coletica). Aliquots of 0, 12.5, 25 and 50pl of this stock were added
to eppendorf tubes as was 50pl of each of the unknown samples. Acetic acid (0.5M)
was added to give a final volume of lOOpl. After addition of lml of Sircol dye
reagent the tubes were mixed on a blood tube rotator for 30 minutes at room
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temperature. The tubes were then centrifuged at 10,000g for 5 minutes and the
supernatant containing unbound dye was removed. To further remove excess dye
solution the tubes were inverted and wiped with an absorbant paper tissue taking care
not to disturb the pellet. The pellet was then redissolved in 1 ml of 0.5M sodium
hydroxide and the absorbance at 540nm for each sample was measured in a
Pharmacia Biotech Ultraspec 2000 UV/VIS spectrophotometer using water as a
blank. The collagen concentration for the unknown samples was calculated from the
standard curve.
2.6.2.2 Hydroxyproline assay
The method ofWoessner et. al. (1961) was used to measure the hydroxyproline
content of samples and thus the amount of collagen present. lOOpl of samples to be
tested were placed in 2ml Multi-max Seal tubes (Sorenson Bioscience) and 1.2ml 6M
HC1 was added. The tubes were sealed and hydrolysed overnight at 107°C. Samples
were transferred to glass tubes and dessicated to dryness for 24-48 hours under
vacuum in a dessicator containing NaOH pellets and silica gel. Samples were then
resuspended in 1ml of dhLO and lOOpl aliquots were removed and made up to
500pl. Hydroxyproline standards containing 0, 2.5, 5, 10, 20, 30, 40, 50 nmoles/ml
were set up. A total of 500pl of standards and samples to be assayed were placed in
fresh test tubes and 0.5ml of 2-methoxyethanol was added, followed by 0.2ml
chloramine T solution (21mM citric acid, 335mM sodium acetate, 102mM trisodium
acetate, 38.5% (v/v) 2-methoxyethanol, 2% (w/v) chloramine T, pH 6.0). After
mixing, each tube was incubated at room temperature for 5 minutes. A volume of
0.3ml of Ehrlich's reagent (87.5% (v/v) 2-methoxyethanol, 12.5% (w/v)
p-dimethylaminobenzaldehyde, 12.5% (v/v) concentrated HC1) was then added
followed by incubation at 70°C for 15 minutes. Finally the tubes were cooled to room
temperature and the absorbance at 553nm was measured in a Pharmacia Biotech
Ultraspec 2000 UV/VIS spectrophotometer. The amount of hydroxyproline in each
sample was calculated from the standard curve and the collagen content calculated
assuming collagen I contains 10% hydroxyproline (Berg, 1982).
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2.7 Affinity purification of TRAMP antiserum using TRAMP immobilised on
nitrocellulose
The above method is useful for affinity purification of antibodies when purified
antigen is not available since the protein of interest can be separated from
contaminants by SDS-PAGE prior to blotting onto nitrocellulose (Smith and Fisher,
1984).
One ml of partially purified TRAMP (~lmg) was loaded onto a 12% acrylamide gel,
with a single well spanning the width of the gel, and was subjected to electrophoresis
(section 2.3). The proteins were then transferred to nitrocellulose as described
previously (2.4.1) and visualised with 0.4% (w/v) Ponceau S in 3% TCA (w/v). The
band corresponding to TRAMP was excised and the bottom right hand corner
removed to allow identification of the antigen face. The affinity strip was blocked
with TBS (50mM Tris-HCl, 0.15M NaCl, pH 7.4) containing 5% (w/v) dried milk,
1 % (v/v) Tween-20 for 90 minutes with shaking. After washing the strip in TBS
containing 1% (v/v) Tween-20 for 1 x 15 minutes and 2x5 minutes, the strip was
placed on parafilm (antigen side up) in a humidity chamber (see figure 2.1).
Figure 2.1. Schematic diagram showing humidity chamber layout for affinity
purification of TRAMP antiserum.
As much antiserum as could be held on by surface tension (~250jil) was then placed
on the strip and this was incubated at room temperature for 2 hours with gentle
shaking. Excess serum was removed and the strip was washed with 250pl aliquots of
TBST for 1 x 15 minutes and 2x5 minutes before eluting bound antibody from the
strip by incubating with 250pl of 0.2M glycine-HCl, pH 2.8 for 20 minutes with






of 0.1M Tris-HCl, pH 8.5. The elution and neutralisation steps were repeated twice
more to remove as much affinity purified antibody as possible. After pooling the
eluants, 0.1 % (w/v) sodium azide was added and the affinity purified antibodies were
stored at 4°C. The affinity strip was washed in TBST and stored for future use at 4°C,






As discussed previously, TRAMP was first identified as a contaminant in lysyl
oxidase preparations (section 1.6; Cronshaw et al., 1993). The apparent close
association of these proteins has hindered attempts to obtain high purity samples of
TRAMP. Both Macbeath et al. (1993) and Cronshaw et al. (1993) devised methods
involving urea extraction followed by DEAE anion exchange chromatography and an
additional, unusual chromatography step based on the selective interaction of
TRAMP and lysyl oxidase with Sephacryl S-200/S-400 media (Shackleton and
Hulmes, 1990a). However, both these methods required further purification steps
such as Mono Q FPLC and reverse phase HPLC to produce TRAMP of high enough
purity for further analyses. This decreased yields, increased the time scale of
purification and in the case of reverse phase subjected the protein to harsh denaturing
conditions.
The aims of the present study were to produce highly purified, active TRAMP for
fibrillogenesis and enzymatic studies, to improve yields and to decrease the time
scale of the purification procedure.
3.2 Detection methods for lysyl oxidase and TRAMP
Generally, the purification process was monitored spectrophotometrically by
measuring the absorbance at 280nm and also by SDS-PAGE followed by Coomassie
blue or silver staining (section 2.3). Total protein concentrations were measured
using the BCA microtiter plate assay (section 2.6). For specific detection of TRAMP,
SDS-PAGE was followed by western blotting (section 2.4) using a 1:5000 dilution of
polyclonal anti-serum to TRAMP (Forbes et al., 1994). The presence of lysyl oxidase
was monitored using the ultrafiltration assay described in section 2.1. In later
purification attempts, an antibody to lysyl oxidase was made available (by Dr. M.
Ouzzine) and thus detection was also carried out by western blot analysis.
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3.3 Methods for buffer exchange and concentration
Throughout the purification a number of methods were used for desalting/buffer
exchange of protein samples. The method used depended on the volume and
concentration of the sample. For volumes above 1.5ml dialysis was used, whilst gel
filtration on prepacked Sephadex G-25 HiTrap desalting columns (Pharmacia) was
used for volumes between 200pl and 1.5ml. For sample volumes below 200fil, gel
filtration was performed using Biogel P-6DG (Biorad) as follows. Briefly, ~1,5ml of
preswollen Biogel was placed in an Eppendorf tube with a small hole punched in the
base which was plugged with glass wool. After pre-equilibrating with the appropriate
buffer, excess liquid was removed from the column by placing the tube in a glass
centrifuge tube and centrifuging for 1 minute at lOOOrpm in a MSE bench centrifuge.
The sample was placed on top of the gel and left to stand for 1 minute before
centrifuging for a further minute at lOOOrpm to collect the protein sample. This
method (courtesy of Dr. D. Apps) was particularly useful since sample dilution was
minimal.
3.4 Purification methods
Unless otherwise stated all procedures were carried out at 4°C. Also, in initial stages
of the purification, all buffers contained ImM PMSF to inhibit serine protease
activity.
3.4.1 Urea extraction
Urea extraction was carried out as previously described by Macbeath et al. (1993).
The skins from 6 to 10 stillborn pigs were diced, fed through a pre-chilled mincer
and homogenised in PBS (0.09M Na2HPC>4, 0.01M NaEMPCE, 0.15M NaCl, pH 7.8)
at 2ml/g in a Waring Blender for 3 x 20 seconds at high speed. The extract was then
centrifuged at 10,000g for 20 minutes and the supernatant was discarded. This
washing step was then repeated once with PBS and 3 times with PB (9mM Na2HPC>4,
1 mM NaFEPCE, pH 7.8) at 2ml/g with centrifugation as above. The pellet was then
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extracted overnight in 6M PBU (9mM Na2HP04, ImM NaH2P04, 6M urea, pH 7.8)
at lml/g of original tissue, again centrifuged as above and the supernatant was
retained. This extraction procedure was repeated twice (for 8 hours and overnight
respectively), the supernatants were then pooled and filtered through Whatman No.
113V filter paper and further clarified by centrifugation at 12,000g for 1 hour.
3.4.2 DEAE-Sephacel anion exchange chromatography
DEAE anion exchange chromatography is often used in the initial stages of lysyl
oxidase purification and thus has been incorporated into TRAMP purifications
(Macbeath et al., 1993; Cronshaw et al., 1993).
In initial experiments the urea extract was loaded onto the DEAE-Sephacel column
(Pharmacia; 2.6cm x 20cm), pre-equilibrated with 6M PBU, at a flow rate of
35ml/hour. The column was then washed with 1 column volume of 6M PBU
followed by 2 column volumes of lOmM Bis-Tris containing 6M urea, pH 6.0 (flow
rate 80ml/hour). Proteins were eluted from the column either by 1 step elution with
lOmM Bis-Tris, 6M urea, pH 6.0 containing 0.5M NaCl as described by Macbeath et
al. (1993) or with a salt gradient from 0 to 0.5 M NaCl in lOmM Bis-Tris, 6M urea,
pH 6.0 at a flow rate of 60ml/hour. The stepwise elution was found (by SDS-PAGE
and lysyl oxidase assay) to be unsuitable for removal of both lysyl oxidase and other
contaminating proteins from TRAMP (data not shown). In contrast, during the
gradient elution the majority of contaminating proteins were eluted from the column
at salt concentrations of between 0 and 0.25M, whilst TRAMP was eluted towards
the end of the gradient (Figure 3.1). However, it should also be noted that although
some lysyl oxidase eluted towards the beginning of the gradient, a significant amount
co-eluted with TRAMP (Figure 3.1a). Changing the pH of the Bis-Tris buffer to 7.0
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Figure 3.1. DEAE-Sephacei anion exchange chromatography of the urea
extract, (a) Proteins were eluted from the column with a gradient of 0 to 0.5M
NaCl in lOmM Bis-Tris, 6M urea, pH 6.0. Values for lysyl oxidase activity are
expressed after subtraction of blanks containing 0.2mM (3-APN (b) SDS-PAGE
analysis of urea extract (U) and fractions (36 to 64) from DEAE-Sephacel
column. T represents TRAMP standard.
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3.4.3 Selective interaction with Sephacryl S-400 media
Following a stepwise elution from the DEAE-Sephacel column, fractions containing
TRAMP were pooled, concentrated (in an Amicon stirred cell concentrator using a
YM10 membrane) and dialysed against 3 changes of PB (9mM NaiHPCU, ImM
NaH2PC>4, pH 7.8). Aliquots of this sample (1.5ml; lOmg) were loaded onto
Sephacryl S-400 test columns (Pharmacia; 1.3 x 20cm), washed with PB and then
eluted with either 6M PBU only or 1.5M PBU followed by 6M PBU (Cronshaw et
al., 1993). Elution with 6M PBU only, resulted in elution of both lysyl oxidase and
TRAMP in a single fraction (data not shown). A small amount of TRAMP was
detectable by SDS-PAGE and silver staining after elution with 1.5M urea. However,
the majority of TRAMP remained bound to the column until addition of 6M urea led
to the co-elution of TRAMP and lysyl oxidase (Figure 3.2).
3.4.4 Affinity purification on amino hexyl Sepharose
Amino hexyl Sepharose chromatography has been used for affinity purification of a
number of mammalian copper amine oxidases, including bovine serum amine
oxidase (BSAO; Houen et. al., 1993). A 1,6-diaminohexane spacer group covalently
linked to Sepharose 4B acts as the ligand for binding of amine oxidases which can
then be eluted, depending on the strength of binding, by increasing the ionic strength
of the buffer or by addition of octylamine. Since lysyl oxidase is also a copper amine
oxidase the same method was used in an attempt to separate it from TRAMP.
A sample volume of 25ml (~4.5mg protein) of the DEAE fraction after stepwise
elution was dialysed against 4 changes of lOmM PB, pH 7.2 and loaded onto an
amino hexyl (EAH) Sepharose 4B column (Pharmacia; 1.6 x 5cm) pre-equilibrated
with the same buffer. After washing with PB to remove unbound material, proteins
were eluted with a gradient of lOmM to lOOmM PB, pH 7.2 followed by lOOmM PB,
pH 7.2 containing lOmM octylamine. The major peak of lysyl oxidase activity was
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Figure 3.2. Sephacryl S-400 chromatography of pooled fractions from
DEAE-Sephacel. (a) Elution profile from Sephacryl S-400 column. Addition
of 1.5M and 6M PBU is denoted by arrows. Fractions 4 and 16 to 25 were
assayed for lysyl oxidase activity and values obtained are expressed after
subtraction of blanks containing 0.2mM (3-APN. (b) Peak fractions (4, 16 and
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Figure 3.3. Amino hexyl Sepharose chromatography of the DEAE 0.5M
NaCl eluate. (a) Elution profile is shown with a gradient from 10 to lOOmM
PB, pH 7.2 (diagonal line) followed by addition of lOmM octylamine
(vertical arrow). Lysyl oxidase activities are expressed after subtraction of
blanks containing 0.2mM (3-APN. (b) Western blot analysis identified
fractions containing TRAMP. T represents TRAMP standard, D the DEAE
fraction prior to loading and lanes 1 to 8 correspond to fractions labelled 1 to
8 in (a).
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Western blot analysis showed the presence of TRAMP in all fractions after ~70mM
PB (Figure 3.3b). It should be noted that octylamine containing fractions were not
dialysed to remove octylamine prior to use in the lysyl oxidase assay. This may have
resulted in a false negative result for the absence of lysyl oxidase in fractions eluted
after addition of octylamine.
3.4.5 Preparative isoelectric focusing
The Biorad Rotofor cell can be used for preparative isoelectric focusing in free
solution and is based on separation of proteins by differences in their isoelectric
points (pi). This method has previously been reported to separate proteins with pi
differences of about 0.6 (Curnette et ai, 1989) and manufacturer's literature suggest
that by narrowing the pH range of the ampholytes used, proteins with differences in
pi values of as little as 0.1 could be resolved. It would thus appear to be a powerful
technique for the separation of TRAMP and lysyl oxidase.
An aliquot of the DEAE step-wise eluate (~8mg protein) in lOmM Bis-Tris, 3M urea,
pH 7.0 (58ml) was mixed with a Biolyte ampholytes mixture (Biorad; 5 parts
Biolytes 3/10 and 1 part Biolytes 3/5) to give a final ampholyte concentration of 2%.
The sample was focused in a Biorad Rotofor cell according to the manufacturer's
instructions at 15 Watts constant power until a constant voltage was maintained (~ 4
hours). Fractions were collected by suction and were analysed by SDS-PAGE and
lysyl oxidase assay.
Figure 3.4a shows the peak of lysyl oxidase activity in fraction 5 which corresponds
to a pH of 4.61. This compared to pi values for lysyl oxidase obtained by analytical
IEF of between 5.2 and 5.8 (Cronshaw, 1993; Macbeath, personal communication).
Electrophoretic analysis showed TRAMP to be present in fractions 3, 4 and 5
corresponding to a pH range of 4.01 to 4.61 (Figure 3.4b). This is in agreement with
the pi values calculated by analytical IEF for the 5 variants of TRAMP which are in
the range 4.07 to 4.43 (Macbeath et al., 1993). The similarity in the apparent pi
values of lysyl oxidase and TRAMP precluded the use of preparative isoelectric
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Figure 3.4. Preparative isoelectric focusing of DEAE fractions in Biorad
Rotofor cell, (a) Graph showing pH gradient and lysyl oxidase activity (after
subtraction of blanks containing 0.2mM (3-APN) of fractions after IEF.
Fractions 3 to 10 were assayed for lysyl oxidase activity, (b) SDS-PAGE and
Coomassie staining of fractions 1 to 6 and the DEAE fraction prior to
focusing (D).
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3.4.6 Superdex-75 size exclusion chromatography
Superdex-75, comprised of highly crosslinked porous agarose beads onto which
dextran is covalently bonded, separates proteins within the molecular mass range
3000 to 70,000 daltons.
Following gradient elution from the DEAE-Sephacel column, fractions containing
TRAMP, as judged by SDS-PAGE and Coomassie staining, were pooled (~ 400ml)
and concentrated to between 1 and 5ml using a YM10 membrane in an Amicon
stirred cell concentrator, followed by further concentration with Centricon-10
microconcentrators centrifuged at 5,000g. The concentrated sample (maximum
volume, 3.5ml) was then applied to a Pharmacia prepacked Hiload Superdex-75 size
exclusion column (2.6cm x 60cm), pre-equilibrated with 6M PBU, pH 7.8 containing
0.5M NaCl at room temperature. Proteins were eluted from the column with this
same buffer at a flow rate of 20 ml/hour and fractions were collected every 30
minutes. Fractions were analysed by SDS-PAGE and lysyl oxidase assay. Figure 3.5a
shows the elution profile from the Superdex-75 column after loading 3.5ml of the
concentrated protein (60mg). There were 3 major peaks of absorbance at 280nm.
SDS-PAGE followed by Coomassie blue staining showed the first peak (Ve, 100ml)
to contain high molecular weight material (Figure 3.5b, lane 1) whilst the third peak
(Ve, 210ml) appeared to contain low molecular weight material which could not be
visualised on a 12% acrylamide separating gel (data not shown). A single protein
band of ~22kDa, corresponding to TRAMP, was observed in fractions from the
second peak (Ve, 150ml; Figure 3.5b, lanes 2-4). However, lysyl oxidase co-eluted
with TRAMP (Ve, 150ml), although the major peak of lysyl oxidase activity was
eluted after 140ml (Figure 3.5a, peaks 2 and 3). Thus despite the use of a relatively
low flow rate to improve resolution, the similarity in the molecular weights of
TRAMP and lysyl oxidase precluded their separation under these conditions.
Partial separation of the two proteins was only obtained after decreasing both the
sample volume and the total amount of protein loaded. Figure 3.6a shows the elution









Figure 3.5. Superdex-75 size exclusion chromatography in the presence of
urea, (a) Elution profile after loading 3.5ml (60mg) of pooled, concentrated
DEAE fraction at a flow rate of 20ml/hour. Fractions with Ve between 120 and
180ml were assayed for lysyl oxidase activity (values are expressed after
subtraction of blanks containing 0.2mM (3-APN). (b) SDS-PAGE followed by
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Figure 3.6. Superdex-75 size exclusion chromatography in the presence
of urea, (a) Elution profile after loading 1.5ml (25mg) of pooled,
concentrated DEAE fraction in 20mM sodium phosphate, 0.5M NaCl, 6M
PBU, pH 7.8. Flow rate 20ml/hour. Fractions 2 to 7 were assayed for lysyl
oxidase activity (b) SDS-PAGE followed by Coomassie blue staining of peak






Blue Dextran 2000 118.4 - -
Albumin 127.4 0.045 63,300
Ovalbumin 136.5 0.091 42,700
Chymotrypsinogen A 172.9 0.273 19,500
Ribonuclease A 191.1 0.363 15,500
Lysyl oxidase 160 0.208 28,140*
TRAMP 172 0.268 21,517*
Table 3.1. Calibration of Superdex-75 size exclusion column. Calibration was
carried out according to the manufacturers instructions using a Pharmacia LMW
calibration kit. For calculation of Kav values, V0 and Vt were taken as 118.4ml and
318.6ml respectively. *The molecular weights of lysyl oxidase and TRAMP were
calculated from a graph of Kav v log MW for protein standards.
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oxidase activity eluted between 155 and 165ml with the majority of TRAMP eluting
between 165 and 185ml. The Superdex-75 column was calibrated with a Pharmacia
low molecular weight calibration kit (containing blue dextran, ribonuclease A,
chymotrypsin A, ovalbumin and albumin) and gave molecular weight values for lysyl
oxidase and TRAMP of 28 and 21.5kDa respectively (Table 3.1). Thus, in the
presence of urea, both TRAMP and lysyl oxidase were eluted according to their
molecular weights. Purification of TRAMP by this method resulted in yields of
1 Opig/g wet weight starting material (Table 3.2).
An alternative method of separating TRAMP and lysyl oxidase by gel filtration was
attempted, based on the suggestion that lysyl oxidase forms aggregates in the absence
of urea (Jordan et al., 1977). Thus, running the Superdex-75 column in lOmM PB,
pH 7.8 containing 0.5M NaCl but in the absence of urea should result in the elution
of aggregated lysyl oxidase in the void volume whilst the elution volume of TRAMP
should remain unchanged. However, Figure 3.7 shows this not to be the case. The
elution volume of lysyl oxidase was between 230ml and 290ml whilst TRAMP
eluted between 300 and 360ml. The delayed elution of both proteins, compared to
that observed in the presence of urea, suggests weak binding to the column. The
yields obtained by this method were 6jig TRAMP per gram wet weight of starting
material (Table 3.3).
3.4.7 Hydrophobic interaction chromatography
Hydrophobic interaction chromatography is based on the interactions between
hydrophobic regions within proteins and immobilised hydrophobic ligands under
conditions of high salt. Thus in general, proteins are loaded onto the column in high
salt and eluted with a gradient of decreasing salt concentration (Roe, 1989).
In an attempt to further improve yields of TRAMP, Superdex-75 fractions containing
a mixture of TRAMP and lysyl oxidase were subjected to hydrophobic interaction
chromatography using a Gilson HPLC system at room temperature. Fractions from























1190 625 744 V -
2 DEAE-
Sephacel
1180 103 121 V -
3 Concentration 3 19333 59 - -
4 Superdex-75
(1)
30 126 3.8 X 10
5 Superdex-75
(2)
25 128 3.2 V -
6 Concentration
and desalting
2 908 1.8 V -
7 Octyl
Sepharose HIC
10 120 1.2 X 1.5
4 & 7 - - - - X 11.5*
Table 3.2. Purification table showing results of a typical TRAMP preparation
with separation by DEAE-Sephacel anion exchange and Superdex-75 size
exclusion chromatography in the presence of urea. Superdex-75 (1) represents
fractions free from lysyl oxidase whilst Superdex-75 (2) represents fractions
containing both TRAMP and lysyl oxidase and thus taken for further purification.

































Figure 3.7. Superdex-75 size exclusion chromatography in the absence of
urea, (a) Elution profile after loading 1.5ml (45mg) of pooled, concentrated
DEAE fraction, dialysed into 20mM sodium phosphate, 0.5M NaCl, pH 7.8.
Alternate fractions were assayed for lysyl oxidase activity and values were
expressed after subtracting blanks containing 0.2mM (3-APN. (b) SDS-PAGE














































245 652 160 >4 -
DEAE-
Sephacel
375 89 61 V -
Concentration
and Desalting
3.5 12800 33.3 y -
Superdex-75
(no urea)
60 77 4.6 X 5.8
Table 3.3. Purification table for separation of TRAMP by DEAE-Sephacel
anion exchange and Superdex-75 size exclusion chromatography in the absence
of urea.
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to buffer exchange on a HiTrap desalting column pre-equilibrated with the
appropriate starting buffer for hydrophobic interaction chromatography (section 3.3).
Significant amounts of protein were lost during this procedure (Table 3.2) and a
precipitate was observed in samples after buffer exchange, especially in the presence
of 1M (NH4)2S04. The choice of media for hydrophobic interaction chromatography
is not only dependent on the hydrophobicity of the amino acid sequence of a protein
but also on knowledge of the number of hydrophobic amino acids which are surface
exposed when the protein is folded into its tertiary structure (Roe, 1989). Thus, initial
screening experiments were carried out using a HIC media test kit (Pharmacia) which
is comprised of five 1ml prepacked columns containing the following HIC media:
Phenyl Sepharose high performance, Phenyl Sepharose-6 fast flow (low substitution),
Phenyl Sepharose 6 fast flow (high substitution), Butyl Sepharose 4 fast flow and
Octyl Sepharose 4 fast flow. Using a Gilson HPLC system at room temperature,
samples were loaded onto the column at 0.5ml/min in 50mM sodium phosphate, 1M
ammonium sulphate, pH 7.0 and a gradient of decreasing salt was applied. Only the
Octyl Sepharose 4 fast flow column was able to bind TRAMP. However, under these
conditions the binding was so strong that the protein did not elute after removal of
ammonium sulphate (data not shown). Additional attempts to elute TRAMP using
40% (v/v) ethylene glycol failed. Since the strength of binding of the protein is
dependent on the initial salt concentration, the concentration of ammonium sulphate
was lowered to 0.25M. Figure 3.8a shows the elution profile from such a separation
attempt. A small absorbance peak of unbound material was observed in fraction 2
whilst the major peak was found at the very end of the gradient in fractions 27 to 40.
This peak was found, by SDS-PAGE and Coomassie blue staining, to consist of 2
protein bands, one at 21 kDa and another of around 16kDa (Figure 3.8b). Since the
16kDa band was also observed in the sample prior to loading it was believed to be a
degradation product of TRAMP.
Detection of lysyl oxidase was carried out by western blotting with a 1:2500 dilution
of the antiserum raised against recombinant human lysyl oxidase (a gift from Dr. M.
Ouzzine). Prior to loading onto the column, 4 bands were observed on the blot at




















Figure 3.8. Separation of TRAMP and lysyl oxidase by octyl sepharose 4
fast flow hydrophobic interaction chromatography. Fractions from
Superdex-75 containing both lysyl oxidase and TRAMP were loaded onto an
octyl sepharose column in 50mM sodium phosphate, 0.25M ammonium
sulphate, pH 7.0. (a) Proteins were eluted from the column with a gradient of
0.25M to 0M ammonium sulphate in 50mM sodium phosphate at a flow rate of
0.5ml/min. (b) SDS-PAGE and Coomassie blue staining of sample prior to
loading (S) and peak fraction (34). (c) Western blot with antibody to lysyl
oxidase (1:2500 dilution) of sample prior to loading (S) and peak fractions 2, 3
and 28 to 39.
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ascribed to TRAMP and its degradation product (see discussion) whilst the 32 and
26kDa bands were believed to be lysyl oxidase and a degradation product of lysyl
oxidase, respectively. No bands at 32kDa were observed in any fractions eluted from
the octyl Sepharose column suggesting that lysyl oxidase either remained bound to or
precipitated on the column. Attempts to repeat this separation procedure with
mixtures of TRAMP and lysyl oxidase free from degradation products were
unsuccessful. It should also be noted that TRAMP prepared in this way was inactive
in the fibrillogenesis assays described in section 4.2.2 (data not shown).
3.4.8 Mono Q FPLC anion exchange chromatography
Mono Q FPLC anion exchange chromatography has previously been used as a final
step in the purification of TRAMP to separate the 5 charge variants and to eliminate
traces of lysyl oxidase (Cronshaw et al., 1993).
Separation of the charge variants of TRAMP was performed by anion exchange on a
Pharmacia Mono Q HR5/5 FPLC (Fast Protein Liquid Chromatography) column
using a Gilson HPLC system at room temperature. Prior to this, buffer exchange was
carried out on a Pharmacia Sephadex G-10 column pre-equilibrated with 6M TBU,
pH 7.5 (20mM Tris-FICl, 6M urea). All buffers were made up using Milli-Q water
and were filtered and degassed with 0.22pm filters just prior to use. The method of
Macbeath et al. (1993) was used with the following modifications. Samples were
loaded onto the Mono Q FPLC column, pre-equilibrated with 6M TBU, from a 1ml
sample loop and were eluted with a linear gradient from 0 to 1M NaCl in 6M TBU at
a flow rate of lml/min.
Figure 3.9a shows the elution profile obtained after Mono Q FPLC of TRAMP
purified by gradient elution from DEAE-Sephacel followed by size exclusion on
Superdex-75 column in the presence of urea. Four ionic variants were identified
corresponding to variants T2 to T5 previously identified by Macbeath et al. (1993).
Variant T1 was absent. A single 22kDa band was observed for each of these variants
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Figure 3.9. Separation of TRAMP variants by Mono Q FPLC. (a) Purified
TRAMP was loaded on to the column from a 1ml sample loop in lOmM Tris-HCl,
6M urea, pH 7.5 and eluted with a gradient of 0 to 1M NaCI at a flow rate
lml/min. (b) Peak fractions (T2, T3, T4 and T5) were analysed by SDS-PAGE
followed by silver staining. S represents the sample prior to loading.
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3.5 Discussion
DEAE-Sephacel anion exchange chromatography is a good initial technique for
protein purification since it is able to process relatively large sample volumes.
Macbeath et al. (1993) found that at pH 6.0, lysyl oxidase did not bind to the DEAE-
Sephacel column and thus by running the column under these conditions substantial
separation of TRAMP and lysyl oxidase could be achieved. Elowever, in this study
lysyl oxidase remained bound to the DEAE-Sephacel column at pH 6.0 and thus
co-eluted with TRAMP. These contradictory results may be explained by differences
in the loading conditions. Macbeath and co-workers adjusted the pH of the urea
extract prior to loading onto the column, whilst in the present study the extract was
loaded onto the column at pH 7.8 and the pH was subsequently lowered by washing
the column with lOmM Bis-Tris, 6M urea, pH 6.0. Additionally, Macbeath et al.
(1993) used phosphate buffer throughout the DEAE step as opposed to the Bis-Tris
buffer used here.
Gradient elution from the DEAE-Sephacel column was more successful for the
partial removal of both lysyl oxidase and other contaminating proteins. However,
there were concerns about the effect of exposure of TRAMP to non-physiological pH
conditions for prolonged periods. Thus, since little difference in the elution profile
resulted from carrying out the gradient elution at pH 7.0, DEAE-Sephacel anion
exchange chromatography at pH 7.0 with a gradient from 0 to 0.5M NaCl was judged
to be a good initial technique for the removal of the bulk of contaminating proteins
and partial separation of lysyl oxidase from TRAMP. Previously, four peaks of lysyl
oxidase activity were observed during gradient elution from a DEAE anion exchange
column corresponding to the 4 charge variants of lysyl oxidase (Stassen, 1976; Kagan
et al., 1979). However, in the present study only three peaks were observed
suggesting that only three of the four variants bound to the column under the
conditions used.
The basis of the interactions between both TRAMP and lysyl oxidase and Sephacryl
S-200/S-400 is poorly understood. Kagan and Trackman (1991) suggested that lysyl
oxidase formed aggregates in the absence of urea which were retained at the top of
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the S-200 gel filtration column. Addition of urea would then lead to disaggregation
and elution of lysyl oxidase. Alternatively, the interaction may be more specific. The
separation of lysyl oxidase from TRAMP on a Sephacryl S-400 column could not be
reproduced in the present study. Cronshaw et al. (1993) showed TRAMP to elute
with 1,5M urea and lysyl oxidase with 6M urea whereas in these experiments both
proteins only eluted after addition of 6M urea. It is unclear why such differences
should occur.
Partial separation of TRAMP and lysyl oxidase was achieved by affinity
chromatography on the amino hexyl Sepharose column although significant levels of
high molecular weight contaminants were also present in fractions containing
TRAMP. As expected, lysyl oxidase was found to bind to the amino hexyl Sepharose
column although its affinity for the 1,6-diaminohexane column would seem to be
lower than for bovine serum amine oxidase since octylamine was not required for its
elution. More unexpectedly, TRAMP was also found to interact with the column.
This could represent either a specific interaction with the 1,6-diaminohexane ligand
or an interaction with the Sepharose 4B support. If the former was the case, this
would support the hypothesis that TRAMP is also an amine oxidase (section 1.6.4.3).
TRAMP and lysyl oxidase could not be separated by preparative isoelectric focusing
using the Rotofor cell (Biorad) due to the focusing of lysyl oxidase at a pH below its
reported pi values. Previous pi values for lysyl oxidase (5.2- 5.8), obtained
experimentally by Macbeath et al. (1993) and Cronshaw et al. (1993), were lower
than the theoretical value of 6 calculated from the human lysyl oxidase sequence
using GCG software. It is possible that this discrepancy is the result of post-
translational modifications such as tyrosine sulphation. However, it is unclear why
such discrepancies should occur between values obtained by analytical and
preparative isoelectric focusing. Perhaps focusing in the Rotofor cell did not reach
completion. Alternatively it may be the result of association of lysyl oxidase with
TRAMP.
Superdex-75 size exclusion chromatography in the presence of urea was found to be
the most promising method for the purification of TRAMP. Although separation of
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TRAMP and lysyl oxidase was incomplete, the highest yields of TRAMP were
obtained by this method (Table 3.2). It was also an efficient technique for removal of
other contaminating proteins resulting in TRAMP of high purity. The speed and
reproducibility of this technique was also in its favour.
Running the Superdex-75 column in the absence of urea resulted in complete
separation of TRAMP from lysyl oxidase although yields were lower than in the
presence of urea (Table 3.3). As is the case with Sephacryl S-200/S-400, both
proteins interact with the Superdex-75 media, although the binding appears to be
weaker since urea is not necessary for elution. The interaction with TRAMP is
strongest and thus TRAMP is eluted with a Kav greater than 1, indicative of
interaction of a protein with the size exclusion column. The results also appear to
contradict previous reports that lysyl oxidase aggregates in the absence of urea
(Jordan et al., 1977) although small amounts of both lysyl oxidase and TRAMP were
observed in the high molecular weight peak by western blotting.
Although hydrophobic interaction chromatography on the octyl Sepharose 4 fast flow
column appeared to remove lysyl oxidase from TRAMP, the final yield of TRAMP
was not substantially increased compared to separation by Superdex-75 alone (Table
3.2). This was believed to be due to precipitation of TRAMP in ammonium sulphate
solutions although previously it was reported (Macbeath, 1992) that TRAMP
precipitates at 30% saturation of ammonium sulphate which corresponds to a
molarity of 1.25. The fact that TRAMP only bound to media with the strongest
hydrophobic ligand attached (i.e. octyl Sepharose) is consistent with a protein with
few hydrophobic moieties on its surface. The lack of activity of TRAMP in the
fibrillogenesis assay after purification on the octyl Sepharose column may be the
result of irreversible denaturation of the protein (Gagnon, 1996). The ability of the
lysyl oxidase antibody to recognise TRAMP may be the result of non-specific
binding due to the high amounts of TRAMP present in the sample relative to lysyl
oxidase. Alternatively it may have been the result of cross reactivity due to sequence
similarities discussed below.
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The elution profile after Mono Q anion exchange chromatography was identical to
that obtained by Macbeath et al. (1993) except that the first peak (Tl) was absent.
This was most probably the result of lack of binding of Tl to the DEAE-Sephacel
column at low pH.
A common feature of purification methods performed in the absence of urea was the
interaction of TRAMP with the chromatography media. TRAMP interacted with both
Superdex and Sephacryl media and possibly with the Sepharose 4B support of the
amino hexyl column. Additionally, TRAMP interacts with DEAE-Sephacel in the
absence of urea (Cronshaw et al., 1993). The requirement of urea for the disruption
of the interactions suggests that they are hydrophobic. However, a more specific
interaction with the polysaccharides within the matrices cannot be ruled out. This
would have implications for the interaction of TRAMP with ECM components
containing carbohydrate moieties, for example proteoglycans. Okamato et al. (1996)
demonstrated such an interaction of TRAMP with decorin, though this appears to be
via the protein core rather than the GAG chain (section 1.6.4).
The difficulties in separating TRAMP and lysyl oxidase may be explained by a
specific interaction between them or by structural and perhaps functional similarities.
Since previous immunoprecipitation studies (Forbes et al., 1994) did not identify a
TRAMP-lysyl oxidase complex, a structural similarity seems more likely. In addition
to similar molecular weights, both TRAMP and lysyl oxidase are hydrophilic
proteins with similar pi values. They also have a number of common features within
their amino acid sequences including hydrophilic N-terminal regions, 2 distinct
tyrosine rich domains and a hydrophobic C-terminal domain (Cronshaw, 1993).
Whether their co-purification is also the result of functional similarities is less clear.
Evidence discussed in chapter 5 refutes the suggestion that TRAMP, like lysyl
oxidase, is an amine oxidase. Thus, the only functional similar between the 2 proteins
to date is their ability to bind collagen fibrils (Macbeath et al., 1993; Cronland et al.,
1985).
Most of the purification methods described in this chapter were able to partially
separate TRAMP from lysyl oxidase. The purification was hampered by problems
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with the identification of lysyl oxidase since at low levels it could not be identified
on Coomassie blue or silver stained gels (Figures 3.2 and 3.5). Until an antibody to
lysyl oxidase became available detection relied solely on the ultrafiltration assay.
Additionally, since a specific assay for TRAMP was not available, direct comparison
of yields was not feasible unless TRAMP was the only protein present after that
particular purification step (Tables 3.2 and 3.3). Techniques which removed all other
contaminants and gave the minimum of overlap between elution of TRAMP and
lysyl oxidase were thus favoured. Other criteria which were considered were the
speed and reproducibility of the method and also its possible denaturing effect on
TRAMP. Thus the purification protocol of choice was DEAE-Sephacel anion
exchange chromatography at pH 7.0 with a gradient elution, followed by
Superdex-75 size exclusion chromatography in the presence of urea and finally Mono
Q FPLC. The yield of lOpg/g wet weight starting material obtained by this method
(Table 3.2) is low compared to the value of 25pg/g obtained by Okamato et al.
(1996) for purification of the bovine equivalent of TRAMP from skin. The method of
Okamato et al. (1996) involved both gel filtration and DEAE anion exchange
followed by 2 reverse phase chromatography steps. The increased yields obtained by
Okamato and co-workers may be explained by the use of 4M guanidine HC1 in place
of urea for the initial extraction procedure. However, it is not known whether the
denaturing effect of guanidine HC1 is reversible and thus whether TRAMP would
still be active in the fibrillogenesis assay (Chapter 4).
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Chapter 4
Interaction of TRAMP with collagen I and decorin
76
4.1 Purification of collagen I monomers
The purification of native monomeric collagen I from lathyritic rat skin (section 2.2)
was judged to be successful according to the following criteria: (i) SDS-PAGE
analysis showed the preparation to consist almost entirely of collagen a-chains, with
the remaining 3% of protein bands comprising multimeric, cross-linked collagen (3
and y components (Figure 4.1). (ii) Scanning densitometry of the Coomassie blue
stained gel showed the ratio of al to a2 chains to be 2:1 suggesting that no collagen
III was present. (Collagen III is present in skin and under reducing conditions the
al(III) chain migrates with a similar electrophoretic mobility to the al(I) chain),
(iii) The absence of collagen III was confirmed when identical gels were obtained
under both reducing and non-reducing conditions (Figure 4.1). (Collagen III contains
reducible disulphide bonds and therefore migrates more slowly under non-reducing
conditions), (iv) No bands were detected after Alcian blue staining (section 2.3.2.3)
showing that the preparation was free from contaminating proteoglycans. The yields
of collagen I were high, with typically 400pg/g wet weight of starting material
obtained.
The overall time required for the purification ofmonomeric collagen I from lathyritic
rat skin, including the 3 week period in which rats were fed on the diet containing
(3-APN, was typically 6 weeks. In view of time constraints, a commercial supplier
was investigated as a possible alternative source of collagen. Collagen I in 0.5M
acetic acid was obtained from Coletica (courtesy of Dr. D. Herbaage) and found by
SDS-PAGE analysis to have approximately equal ratios of a, (3 and y components.
The presence of large amounts of cross-linked components was judged to be
unacceptable and therefore attempts were made to remove high molecular weight
components by differential salt precipitation and fibril formation. Aliquots were
taken and 20% (w/v) NaCl was slowly added to a final concentration of 3.5% (w/v)
to precipitate out aggregates (Chandrakasen et al., 1976). After centrifugation and
dialysis of the supernatant to remove salt, the collagen was formed into fibrils
overnight using the 'warm start' technique (section 4.2.2.1). Fibrils were pelleted by
centrifugation at 15,600g for 10 mins and then extracted overnight in 1. ImM
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Figure 4.1. SDS-PAGE analysis of collagen I purified from lathyritic rat
skin. Analysis by SDS-PAGE with 6% acrylamide in the separating gel under
reducing (R) and non-reducing (NR) conditions. Proteins were visualised by
Coomassie blue staining.
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KH2PO4, 5.4mM Na2HP04, 0.15M NaCl, pH 7.4. SDS-PAGE analysis of the extract
showed no change in the ratio of a, (3 and y components. Thus it proved impossible
to eliminate the cross-linked components and the use of commercial collagen was
abandoned.
4.2 Further characterisation of the TRAMP-collagen interaction
4.2.1 Materials
Hydrogen peroxide, Tween-20, bovine serum albumin, TES and o-phenyldiamine
dihydrochloride were obtained from Sigma Chemicals co., Poole, Dorset. Normal
goat serum and horse radish peroxidase conjugated goat anti-rabbit IgG antibody
were obtained from the Scottish Antibody Production Unit (SAPU), Carluke,
Lanarkshire. Decorin purified from bovine skin was a gift from Professor Paul Scott,
University of Alberta, Edmonton, Canada. All other reagents, unless otherwise stated
were obtained from BDH, Poole, Dorset.
4.2.2 Special methods
4.2.2.1 In vitro fibril formation assay
Lathyritic collagen I monomers (section 4.1) were reconstituted into fibrils using the
"warm start technique" (Holmes et al., 1986). Collagen monomers in 5mM acetic
acid (250pl) and the appropriate double strength fibril formation buffer (250pl) were
preincubated separately at 34°C before mixing in a 1:1 ratio to initiate fibril
formation. The increase in turbidity was monitored at 313nm at 5 min intervals in a
Philips/Unicam 8700 series UV/VIS spectrophotometer. Data was transferred to
Microsoft Excel using Unicam ASDS software. For fibril formation in the presence
of TRAMP or decorin, solutions containing these proteins were subjected to buffer
exchange on 1ml Biogel P-6DG (Biorad; section 3.3), previously swollen and
equilibrated with the double strength fibril formation buffer to be used, and then
diluted in the same buffer prior to use.
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Although collagen solutions were centrifuged (300,000g, 1 hour, 4°C) just prior to
use, and all other solutions were filtered with 0.22|im Millipore filters, initial
experiments gave large sample to sample variations. These variations were
minimised by rinsing all tubes and tips with filtered buffers, using transmission
matched quartz cuvettes with lids (Hellma) rather then plastic disposable cuvettes
and including a final concentration of 100jig/ml BSA in the cuvette. The presence of
BSA is believed to prevent non-specific absorption and protein denaturation due to
interactions with walls of tubes and pipette tips (Brown and Vogel, 1989).
4.2.2.2 Binding assays
4.2.2.2.1 Co-sedimentation assay
To study the interaction of TRAMP with collagen I fibrils under various conditions,
fibrils were formed as described above. The insoluble fibrils were pelleted by
centrifugation at 15,600g at room temperature for 10 mins. The supernatant was
removed and proteins were precipitated by the addition of TCA to a final
concentration of 10% (w/v) followed by incubation on ice for 15 mins, then
centrifugation at 15,600g for 10 mins. Both fibril and TCA pellets were redissolved
in reducing sample buffer (Hames, 1990) and analysed by SDS-PAGE, Coomassie
staining and densitometry (section 2.3). To quantify the amounts of TRAMP found in
the pellet and supernatant, standards containing known amounts of TRAMP were run
on the same gel to give a standard curve of pg of TRAMP versus optical density. To
measure the amounts of collagen in the supernatant and pellet, parallel fibrillogenesis
assays were set up and pellets were redissolved in 0.5M acetic acid and assayed using
the Sircol collagen assay (section 2.6.2.1) or by SDS-PAGE followed by
densitometry. The reproducibility was improved by the inclusion of 100|ig/ml BSA
in the buffer to prevent protein losses.
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4.2.2.2.2 Solid phase assay
A modification of the ELISA method of Hedbom and Heinegard (1989) was used to
measure the binding of TRAMP to collagen I monomers immobilised on microtiter
plate wells.
The wells of a polystyrene microtiter plate (Nunc-Immuno Plate IF, article no.
439454, AS Nunc) were coated with 200|ll of soluble collagen I (5p.g/ml), obtained
by mixing equal volumes of collagen in 5mM acetic acid and PBS1 (0.27M NaCl,
60mM sodium phosphate, pH 7.4) at 4°C. Control wells were coated with the same
concentration of BSA. The plate was incubated at 4°C overnight in a humidity
chamber before crosslinking absorbed protein by treatment with 0.25% (v/v)
glutaraldehyde in 0.15M NaCl, 0.5mM NaCNBPE, 20mM TES, pH 7.4 for 2.5 hours
at 37°C. The remaining reactive groups were then blocked by incubating wells for 30
mins at 37°C with 0.2M ethanolamine in the same buffer. After washing with 5 x
200JJ.1 of PBS2 (0.14M NaCl, 5mM sodium phosphate, 0.05% Tween-20, pH 7.4),
non-specific binding was blocked with 200|il/well of PBS3 (PBS2 containing
lOOmg/ml BSA) for 4 hours at room temperature. Wells were washed with 5 x 200|ll
PBS4 (0.14M NaCl, 30mM sodium phosphate, 0.05% Tween-20, pH 7.4) and
incubated with 200|ll TRAMP in PBS4 overnight at room temperature with gentle
shaking. The washing step was repeated and 200jil of anti-TRAMP antibody was
added to each well and incubated overnight at 4°C. The plate was again washed
before incubation with 200jll/well of a 1:5000 dilution of horse radish peroxidase
(HRP) conjugated goat anti-rabbit IgG antibody for 2 hours at room temperature. A
final washing step was followed by incubation in the dark for 40 mins with
200|il/well 0.4mg/ml o-phenyldiamine dihydrochloride (OPD) in phosphate-citrate
buffer (0.05M NaoHPO^ 0.024M citric acid, pH 5.0) containing 0.4pl/ml H2(X The
reaction was stopped with the addition of 50|ll 3M sulphuric acid and the absorbance
at 490nm was measured in a Dynatech MR7000 microplate reader. All experiments
were carried out in triplicate and controls were included in the absence of collagen or
TRAMP.
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4.2.3 Effect of buffer system on interaction with fibrils
As discussed previously, TRAMP interacts with collagen I fibrils reconstituted in
vitro and accelerates their formation in 30mM Na2HP04, 30mM TES, 135mM NaCl,
pH 7.4 at 34°C (section 1.6.4.2; Macbeath et al., 1993). This buffer produces fibrils
which are morphologically identical to fibrils observed in vivo (Williams et al.,
1978). However, the concentrations of phosphate and TES in this buffer are not
compatible with physiological conditions. Also, both phosphate and TES
concentrations are known to affect the kinetics of fibril formation in vitro (Williams
et al., 1978; Pogany et al., 1994). It was thus pertinent to study the effect of
phosphate and TES concentrations on the ability of TRAMP to accelerate collagen
fibril formation and on the binding of TRAMP to these fibrils.
4.2.3.1 Kinetics of fibril assembly
The effect of phosphate and TES concentration on the ability of a mixture of
TRAMP variants (T2 to T5) to accelerate fibril formation was assessed using the
fibril formation assay (section 4.2.2.1) with a final concentration of 100|ig/ml
collagen. Fibril formation was almost completely inhibited in TES buffer (30mM
TES, 135mM NaCl, pH 7.4) containing 30mM phosphate both in the presence and
absence of 5jlg/ml TRAMP (Figure 4.2a). By comparison, initiation of fibril
formation in TES buffer containing lOmM phosphate in the absence of TRAMP
resulted in a characteristic sigmoidal turbidity-time curve (Figure 4.2a; section 1.7;
Figure 1.3). This observation is in agreement with previous reports showing that
increasing phosphate concentrations have an inhibitory effect on the kinetics of fibril
formation (Williams et al., 1978; Pogany et al., 1994). Figure 4.2a also shows that
the acceleratory effect of TRAMP on fibril formation, characterised by a decrease in
the lag phase and an increase in final turbidity, is still observed in lOmM phosphate.
Figure 4.2b demonstrates the effect of TES on fibril formation in the presence and
absence of 5pg/ml TRAMP in lOmM PBS buffer (7.7mM Na2HP04, 2.3mM
NaH2P04, 135mM NaCl, pH 7.4). In the presence of 30mM TES the lag phase was
~5 mins, t]/2 was 16 mins and the final turbidity was 0.358. In contrast, when fibrils
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Figure 4.2. Effect of phosphate and TES concentration on collagen fibril
formation in vitro. Fibril formation was intiated using the 'warm start' technique.
After preincubation at 34°C, collagen I in 5mM acetic acid and double strength buffer
were mixed in a 1:1 ratio to give a final [collagen] of lOOpg/ml. The increase in
turbidity at 313nm was monitored every 5 mins for 180 mins. All buffers contained
135mM NaCl. Appropriate phosphate buffer (PB) concentrations were achieved by
diluting 60mM PB (46.4mM NaiHPCU, 13.6mM NaKWPCU, pH 7.4). For fibrils
formed in the presence of TRAMP, the final [TRAMP] was 5pg/ml. Total sample
volume in the cuvette was 0.5ml.
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were formed in the absence of TES, ti/2 was decreased to 14 mins and the final
turbidity was increased to 0.711. The change in lag phase could not be accurately
measured. The inhibitory effect of TES on collagen fibril formation is in agreement
with previous reports (Pogany et al., 1994). Figure 4.2b also shows that TRAMP was
still able to accelerate fibril formation in the absence of TES judged by a decrease in
11/2 to 9 mins and an increase in final turbidity to 0.749.
4.2.3.2 Binding to fibrils
Collagen fibrils were formed overnight at 34°C at various phosphate and TES
concentrations with lOOpg/ml collagen and 5pg/ml TRAMP and the effect on the
binding of TRAMP to fibrils was assessed using the co-sedimentation assay
described in section 4.2.2.2.1 (Table 4.1). In TES buffer (30mM TES, 135mM NaCl,
pH 7.4) containing 30mM phosphate, 7% of the total TRAMP present was found in
the pellet. When the phosphate concentration was reduced to lOmM the amount of
TRAMP in the pellet was increased to 12% of the total. Removal of TES from this
buffer resulted in a further increase to 21%. It appears therefore that both phosphate
and TES have an inhibitory effect on TRAMP binding to collagen. However,
differences in the composition of the fibril formation buffer also affect the amount of
collagen formed into fibrils, hence the ratios of TRAMP to collagen found in the
supernatant and the pellet were also compared under the different conditions. The
ratio of TRAMP to collagen was decreased when the phosphate concentration was
lowered to lOmM suggesting that less TRAMP was associated with collagen at lower
phosphate concentrations. In contrast, removal of TES from buffer containing lOmM
PB, 135mM NaCl, pH 7.4 appeared to have no further affect on the ratio of TRAMP
to collagen and thus on the amount of TRAMP associated with collagen fibrils.
4.2.3.3 Binding of TRAMP to collagen fibrils after formation
Previous studies on binding of TRAMP to in vitro reconstituted collagen fibrils
looked only at the ability of TRAMP to bind fibrils as they form (Macbeath et al.,
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Table 4.1. The effect of phosphate and TES concentration on TRAMP binding
to collagen I fibrils. Amounts of TRAMP (determined by scanning densitometry)
and collagen (determined by sircol assay) in pellets (P) and supernatants (S) after
centrifugation of fibrils formed at 34°C for 16 hours in various buffer systems.
Reaction volume was 500|ll. All buffers contained 135mM NaCl and appropriate
phosphate buffer (PB) concentrations were achieved by diluting 60mM PB (46.4mM
NaiHPCU, 13.6mM Na2HP04, pH 7.4). Data represent means ± standard errors (n=4).
85
1993). Since TRAMP is postulated to have a role in the initial nucleation phase of
fibrillogenesis, experiments were devised to study the binding of TRAMP to fibrils
previously formed in the absence of TRAMP. Fibril formation was initiated in
Eppendorf tubes using the 'warm start- technique (section 4.2.2.1) in 30mM TES,
30mM NaaHPO^ 135mM NaCl, pH 7.4 with 600pg/ml collagen in a final volume of
250pl. After allowing fibrils to form for 20 hours at 34°C, 250pl of the same buffer
containing lOpg/ml TRAMP was carefully layered on top of the collagen gel
followed by further incubation for 20 hours at 34°C. The amount of TRAMP
associated with fibrils was assessed using the co-sedimentation assay (section
4.2.2.2.1). The results show that TRAMP does not associate with collagen I fibrils if
not present during their formation (Figure 4.3). Furthermore, no TRAMP was found
associated with fibrils formed in the presence of lOpg/ml TRAMP and then layered
with buffer alone. In contrast, TRAMP was still found associated with collagen
fibrils after a 40 hours incubation period if the mixture was not layered with buffer
(Figure 4.3).
4.2.4 Effect of sulphatase-treated TRAMP on the kinetics of fibril assembly
TRAMP is known to contain sulphated tyrosine residues (section 1.6.2; Forbes et al.,
1994). To determine whether sulphation was involved in the acceleratory effect of
TRAMP on fibril assembly, sulphate groups were partially removed by treatment
with aryl sulphatase.
For sulphatase treatment, 275pg of TRAMP in 0.1M sodium acetate, pH 5.0 was
incubated with 1.25 units of aryl sulphatase sulphohydrolase from Helix pomatia
(E.C. 3.1.6.1; Boehringer Mannheim) for 2 hours at 37°C in a total volume of 1ml
(Forbes et al., 1994). TRAMP was then separated from the sulphatase by size
exclusion chromatography on a Sephadex G50 column (1.3 x 30cm) pre-equilibrated
with TES buffer (60mM TES, 60mM Na^HPO^ 270mM NaCl, pH 7.4). For controls,
TRAMP was incubated in 0.1M sodium acetate for 2 hours at 37°C in the absence of
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Figure 4.3. Comparison of binding of TRAMP to fibrils as they form and after
formation. Collagen fibrillogenesis was initiated at time 0 hrs in the presence or
absence of 2.5pg TRAMP. At time 20 hrs, buffer or TRAMP was layered over the
collagen gel and incubated for a further 20 hrs before analysis using the
co-sedimentation assay. In controls, collagen fibrils were formed in the presence of











Figure 4.4. Effect of partial removal of sulphate groups from TRAMP
on collagen fibril formation in vitro. For sulphatase treatment, TRAMP
was incubated with 1.25 units of sulphatase for 2 hours at 37°C in 0.1M
sodium acetate, pH 5.0. Samples before (T) and after (S) sulphatase
treatment were analysed by SDS-PAGE followed by Coomassie (a) or
Alcian (b) blue staining. In lane S diffuse bands at ~67kDa and ~32kDa
correspond to sulphatase and its degradation product, (c) Fibrils were
formed at 34°C in 30mM TES, 30mM Na2HP04, 135mM NaCl, pH 7.4
with 300pg/ml collagen and when present, lOpg/ml TRAMP. Total volume
in cuvette was 0.5ml.
a b
T S T S
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sulphatase-treated TRAMP were then tested in the fibril formation assay (section
4.2.2.1).
Samples of TRAMP before and after sulphatase treatment were subjected to SDS-
PAGE, stained with either Coomassie or Alcian blue and analysed by densitometry.
Alcian blue staining of TRAMP was reduced by 50% relative to Coomassie blue
staining after sulphatase treatment (Figure 4.4a,b) which is consistent with previous
reports (Cronshaw et al., 1993). Thus, approximately half of the sulphate groups on
TRAMP were removed by sulphatase treatment. Figure 4.4c shows that the partial
removal of sulphate groups had no affect on the ability of TRAMP to accelerate fibril
formation in vitro.
4.2.5 Interaction with monomers
The interaction of TRAMP with collagen monomers has not previously been studied
in detail, though preliminary results using fluorescence polarisation and rotary
shadowing indicate that such interactions may occur (Macbeath, 1992).
Initial experiments using the solid phase assay (section 4.2.2.2.2) showed clear
binding of TRAMP (0.5pg/well) to collagen coated wells (lpg/well) using a 1:5000
dilution of primary antibody (Figure 4.5). However, high levels of non-specific
binding were observed in the absence of TRAMP. This high background was reduced
by using the antibody after affinity purification on a TRAMP-nitrocellulose strip as
described in section 2.7 (Figure 4.5).
The binding capacity of TRAMP for collagen coats was investigated by titration of a
fixed amount of collagen (lpg/well) with increasing concentrations of TRAMP
(Figure 4.6). TRAMP binding increased rapidly up to 2.5pg/ml TRAMP and then




Figure 4.5. Effect of affinity purification on antibody specificity. Microtiter
plate wells coated with 5pg/ml collagen were incubated overnight at room
temperature with PBS4 alone or PBS4 containing 2.5pg/ml TRAMP and then
incubated with antiserum to TRAMP before (A, 1:5000 dilution) or after (AP,
1:10 dilution) affinity purification. Controls were included in which wells were
coated with 5(ig/ml BSA in place of collagen and data is expressed after
subtraction of control values. Error bars represent standard errors (n=3).
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Figure 4.6. The binding capacity of TRAMP for collagen I monomers. Microtiter
plate wells coated with 5pg/ml collagen were incubated at room temperature for 16
hours with various concentrations of TRAMP in PBS4. Bound protein was
quantitated by ELISA as described in section 4.2.2.2.2 using a 1:20 dilution of
affinity purified antiserum and a 1:5000 dilution of anti-rabbit IgG antibodies
conjugated to horse radish peroxidase. A control experiment was also carried out in
which wells were coated with 5|lg/ml BSA before incubation with increasing
concentrations of TRAMP and data is expressed after subtraction of these control
values. Error bars represent standard error (n=3).
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4.3 Effect of decorin on the TRAMP-colIagen interaction
The ability of the small dermatan sulphate proteoglycan decorin to bind collagen I
and inhibit collagen fibril formation in vitro is well documented (section 1.7.3; Vogel
et al., 1984). More recently, decorin has been shown to bind 22K ECM protein, the
bovine form of TRAMP (section 1.6.4.2; Okatamo et al., 1996). It was therefore of
interest to study the effect of decorin on the TRAMP-collagen interaction.
4.3.1 Interaction with fibrils
4.3.1.1 Kinetics of fibril assembly
The effect of decorin on collagen fibril formation in the presence and absence of
TRAMP was studied using the 'warm start' technique (section 4.2.2.1) in 30mM
TES, 30mM Na2HP04, 135mM NaCl, pH 7.4 (Figure 4.7). The characteristic
turbidity-time curve was observed when fibrils were formed in the presence of
300pg/ml collagen (lag phase 9 mins; ti/2 40 mins; final turbidity 1.032). As
expected, the presence of 5pg/ml decorin alone inhibited fibril formation, judged by
increases in the lag phase (22 mins) and ti/2 (65 mins) and a decrease in the final
turbidity (0.765). Fibril formation was accelerated in the presence of TRAMP alone;
the lag phase and ti/2 were decreased to 6 mins and 23 mins respectively and the final
turbidity was increased to 1.269. When both decorin and TRAMP were present, the
effect of decorin predominated, although TRAMP partially reversed decorin
inhibition. The lag time (17 mins) and tj/2 (79 mins) were closest to the values
obtained for decorin alone, but the final turbidity tended towards the control value.
Taking the molecular masses of TRAMP and decorin to be 22kDa and 120kDa
respectively, the molar ratio of TRAMP to decorin was 22 to 1. Thus, the inhibitory
effect of decorin predominates even when present at much lower molar amounts.
The combined effect of decorin and TRAMP on collagen fibrillogenesis was also
studied in lOmM PBS, pH 7.4 (Figure 4.8). When present alone, TRAMP accelerated
and decorin inhibited fibrillogenesis although the effects of both were less
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Figure 4.7. The combined effect of TRAMP and decorin on collagen fibril
formation in TES buffer. Fibrils were formed at 34°C in 30mM TES, 30mM
NaiHPCU, 135mM NaCl, pH 7.4 with 300pg/ml collagen and when present 5pg/ml
decorin and 20pg/ml TRAMP. Total sample volume in the cuvette was 0.5ml. Error
bars represent standard errors (n=4).
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Figure 4.8. The combined effect of TRAMP and decorin on collagen fibril
formation in PBS. Fibrils were formed at 34°C in lOmM PBS (7.7mM Na2HP04,
2.3mM NaH2P04, 135mM NaCl, pH 7.4) with 150pg/ml collagen and when present
2.5pg/ml decorin and lOpg/ml TRAMP. Total sample volume in the cuvette was
0.5ml.
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pronounced than in TES buffer. When both TRAMP and decorin were present the
decorin effect was again dominant.
4.3.1.2 Binding to fibrils
The effect of decorin on TRAMP binding to fibrils was studied using the co-
sedimentation assay (section 4.2.2.2.1). When fibril formation was initiated in TES
buffer with 300pg/ml collagen in the presence of 20pg/ml TRAMP, 64% of the
collagen present was found in the pellet and thus formed into fibrils. By contrast,
only 24% of collagen present was formed into fibrils in the presence of both 20pg/ml
TRAMP and 5pg/ml decorin. Despite the decrease in collagen in the pellet, decorin
appeared to have no effect on the amount of TRAMP found in the pellet (Figure 4.9).
After incubating a mixture of 20pg/ml TRAMP and 5pg/ml decorin in the absence of
collagen for 3 hours at 34°C, no TRAMP was found in the pellet (data not shown)
suggesting that the presence of decorin does not cause precipitation of TRAMP.
Thus, it would seem that decorin enhances TRAMP binding to collagen fibrils.
The effect of decorin on TRAMP binding to fibrils formed in lOmM PBS, pH 7.4
was then studied (Figure 4.10). Again, no change in the amount of TRAMP found in
the pellet was observed in the presence of decorin. However, there was also little
difference in the amount of collagen formed into fibrils in the presence and absence
of decorin. Thus, in lOmM PBS, pH 7.4 decorin has no effect on TRAMP binding to
collagen fibrils.
4.3.2 Interaction with monomers
The effect of decorin on TRAMP binding to collagen monomers was investigated
using the solid phase assay (section 4.2.2.2.2). Firstly, TRAMP and various
concentrations of decorin were added simultaneously and incubated for 24 hours in
collagen coated wells (Figure 4.11). A small decrease in binding was observed with
increasing decorin concentration. However, the presence of increasing concentrations









- decorin + decorin
■ TRAMP □ Collagen
Figure 4.9. The effect of decorin on binding of TRAMP to collagen fibrils
formed in TES buffer. Amounts of collagen and TRAMP in the pellet (determined
by scanning densitometry) after centrifugation of fibrils formed for 3 hours with
300pg/ml collagen, 20pg/ml TRAMP and in the presence or absence of 5pg/ml
decorin. Results are expressed as percentage of total collagen and TRAMP present.
Error bars represent standard errors (n=3).
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- decorin + decorin
■ TRAMP □ Collagen
Figure 4.10. The effect of decorin on the binding of TRAMP to collagen fibrils
formed in PBS. Amounts of collagen and TRAMP in the pellet (determined by
scanning densitometry) after centrifugation of fibrils formed for 3 hours with
150pg/ml collagen, lOpg/ml TRAMP and in the presence or absence of 2.5pg/ml
decorin. Results are expressed as percentage of total collagen and TRAMP present.













pg/ml competitor (decorin or BSA)
16
Figure 4.11. Binding of TRAMP to collagen I monomers in the presence of free
decorin. Wells coated with 5pg/ml collagen were incubated with a mixture of
1 pg/ml TRAMP and increasing concentrations of decorin or BSA for 20 hours.
Amount of TRAMP bound was measured using an ELISA with a 1:20 dilution of
affinity purified primary antibody. Error bars represent standard errors (n=2).
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(ig/ ml decorin
■ TRAMP added first □ decorin added first
Figure 4.12. Effect of decorin on binding of TRAMP to collagen I monomers.
Wells coated with 5jig/ml collagen were incubated with lpg/ml TRAMP overnight
followed by various concentrations of decorin for 8 hours ( ■ ) or with various
concentrations of decorin overnight followed by l|ig/ml TRAMP for 8 hours (□ ).
Amount of TRAMP bound was quantified by ELISA with a 1:20 dilution of affinity
purified primary antibody. Absorbance values are expressed after subtraction of
blanks with no TRAMP present. Error bars represent standard errors (n=2).
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protein in the buffer interferes with the TRAMP-collagen interaction. Thus, in order
to eliminate the effect of free protein, experiments were set up whereby TRAMP was
allowed to bind to the collagen coat for 16 hours before incubating for a further 8
hours with decorin at various concentrations (Figure 4.12). In other cases, decorin
was incubated with the collagen coat prior to incubation with TRAMP (Figure 4.12).
Decorin had no affect on binding of TRAMP in either of these cases even when
present at high saturable concentrations of 16pg/ml (Hedbom and Heinegard, 1989).
This suggests that the binding sites for TRAMP and decorin on collagen are distinct.
However, there did appear to be a decrease in binding when decorin was added prior
to TRAMP. Since the effect was also observed in control wells where no decorin was
added, the decrease is most likely to be due to the shorter incubation time with
TRAMP in the second experiment.
4.4 Identification of TRAMP binding sites on collagen fibrils
4.4.1 Immunogold Labelling Technique
The original method used for indirect immunolabelling was based on that of Mould
et al. (1990). Collagen fibrils reconstituted in the presence or absence of TRAMP
were absorbed onto formvar, carbon coated nickel grids (Agar). Non-specific binding
was blocked by floating grids face down on 50pl droplets of PBST (PBS containing
0.05% Tween-20) for 15 mins. Excess liquid was drained off and the grids were
incubated for 2 hours with the appropriate dilution of TRAMP anti-serum diluted in
PBST. Grids were washed on 5x 50pl droplets of PBST for 5 mins each before
incubating for 1 hour with a 5nm gold-conjugated goat anti-rabbit probe diluted in
PBST. The grids were washed on 5x 50pl droplets of dH20 adjusted to pH 8.0 with
NaOH. Finally the grids were positively stained with 1% (w/v) phosphotungstic acid,
pH 2.2 followed by 1% (w/v) uranyl acetate, pH 4.4. Electron micrographs were
analysed using a Semper image analysis programme to measure the distribution of
gold particles along the fibril. Controls were included with preimmune serum or
PBST alone in place of primary antibody. For incubations over 15 mins, grids were
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placed in a humidity chamber. Prior to use, all solutions were filtered with 0.22pm
filter units to remove particulate matter.
4.4.2 Results
Figure 4.13 shows the distribution of gold particles along the D-period of collagen
fibrils formed in vitro in the presence and absence of TRAMP. In the presence of
TRAMP, the majority of gold particles were found between the b| and e2 bands
(Figure 1.1). However, peaks were also observed in this area when fibrils were
formed in the absence of TRAMP and also when the TRAMP antibody was replaced
with pre-immune serum or buffer alone. This suggests that the preference of the gold
probe for the area between the bj and e2 bands is due to non-specific charge
attractions and not binding to TRAMP within the fibril.
Attempts were made to reduce the non-specific binding. The blocking step was
modified so that 10% normal goat serum (Scottish Antibody Production Unit) was
used in place of PBST and the incubation times were increased to 1 hour. Affinity
purified TRAMP antibody (section 2.7) was used and the primary antibody
incubation time was increased to 16 hours at 4°C. Dilutions of primary antibody were
carried out with 0.7mM Na2HPC>4,0.3mM KTDPO4, 150mM NaCl, 0.1 % BSA, 0.1%
Tween-20, pH 7.2. Between primary and secondary antibody incubations the grids
were washed thoroughly on 3 x 50pl droplets of Tris I (0.05M Tris-HCl, pH 7.4) for
1 min each, followed by 3 x 50pl droplets of Tris II (0.05M Tris-HCl, 0.1 % BSA, pH
7.4) for 1 min each and finally on a 50pl droplet of Tris III (0.05M Tris-HCl, 1%
BSA, pH 8.2) for 15 mins. Tris is believed to stabilise bound gold particles (Miss
Kate Gregory, oral communication, August 1996). The second antibody incubation
step was unchanged, after which grids were washed on a series of 50pl droplets for 3
x 1 min on Tris II, 3 x 1 min on Tris I and 3 x 1 min on ddH20. The washing steps
were further improved by constant agitation achieved by placing grids on a drop of
liquid on top of a magnetic stirrer which allows them to rotate.
Figures 4.14 and 4.15 show the results of these modifications. Background levels of
binding of the gold probe to collagen fibrils in the absence of TRAMP antibody were
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Figure 4.13. Immunogold localisation of TRAMP on in vitro reconstituted
collagen I fibrils using polyclonal antiserum to TRAMP. Graph shows
distribution of gold particles along the D-period from the 'c2' band in the absence
and presence of TRAMP. Primary antibody (Ab) was a 1:1000 dilution of polyclonal
antiserum to TRAMP. PIS represents a 1:1000 dilution of pre-immune serum.
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a
Figure 4.14. Typical electron micrographs after immunogold labelling of
collagen 1 fibrils reconstituted in vitro in the absence (a, b) or presence of
TRAMP (c). In (a) grids were incubated with diluting buffer in place of primary
antibody whilst in (b) and (c) the primary antibody was undiluted affinity purified
antiserum to TRAMP. Arrows denote the location of the c^ band. The scale bar
represents 300nm.
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Figure 4.15. Immunogold localisation of TRAMP on in vitro reconstituted
collagen I fibrils using affinity purified antiserum to TRAMP. Graph shows
distribution of gold particles along the D-period from the 'c2' band in the absence
and presence of TRAMP. Primary antibody (Ab) was undiluted affinity purified
antiserum to TRAMP (section 2.7).
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decreased both in the presence and absence of TRAMP, although a small peak was
still observed between the bi and e2 bands in the presence of TRAMP. However, the
modifications were unsuccessful in decreasing non-specific binding in the presence
of primary antibody since a peak of gold particles was again observed between the bi
and e2 bands both in the presence and absence of TRAMP. An overall increase in the
number of gold particles bound to fibrils was observed in the presence of TRAMP
and higher distributions were found between the b2 and bi bands and the a2 and e2
bands. However, the significance of these peaks is unclear since they are close to the
non-specific binding peak and depend on the accuracy of the counting procedure.
These results suggest that there are no specific areas of binding of TRAMP to
collagen fibrils or that non-specific binding is still masking these areas.
4.5 Discussion
The results of this study confirm that reconstituted collagen fibrils similar to fibrils
formed in vivo can be reproducibly obtained from purified lathyritic rat skin collagen
I. Also, lowering the concentrations of phosphate and/or TES increase the rate of
fibril assembly as judged by the change in turbidity over time. The presence of
phosphate and TES ions is known to inhibit fibrillogenesis probably due to their
association with free collagen molecules and/or the growing fibril, thereby disrupting
collagen-collagen interactions (Holmes et al., 1986; Pogany et al., 1994). An
alternative hypothesis suggests that the effect of these anions on fibril assembly is
indirect and due to their ability to increase the order of bulk water, thus making
fibrillogenesis energetically less favourable (Cooper, 1970). It should be noted that
the complete inhibition of fibril formation at 100|lg/ml collagen in 30mM TES,
30mM Na2HPC>4, 135mM NaCl, pH 7.4 contradicts previous reports by Macbeath et
al. (1993). This may be explained by the observation that the kinetics of assembly for
a particular collagen sample are sensitive to the exact method used to purify it. The
present study also shows that TRAMP purified by DEAE-Sephacel anion exchange
followed by Superdex-75 gel filtration and Mono Q FPLC (chapter 3) is still able to
accelerate fibril assembly. Decreasing the phosphate and TES concentration has no
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affect on the ability of TRAMP to accelerate fibrillogenesis, suggesting that TRAMP
would be capable of eliciting this effect under physiological conditions.
The amount of TRAMP associated with collagen fibrils is reduced when the
concentration of phosphate in the buffer is decreased. This may be the result of the
speed at which fibrils are formed at low phosphate concentrations since there would
be less time for TRAMP to bind collagen before fibrillogenesis began. The fact that
removing TES from the buffer had no further affect on the binding of TRAMP to
collagen fibrils suggests that the interaction is not via the sulphate groups on TRAMP
since if this was the case, both phosphate and the sulphonic acid group on TES would
be expected to compete for binding with TRAMP. Thus binding would be more
efficient at low phosphate and TES concentrations.
A number of possible explanations exist for the lack of binding of TRAMP to
pre-formed collagen fibrils. Firstly, any interference with the system during
fibrillogenesis is known to affect the kinetics and morphology of fibrils. Thus,
layering may disrupt the interaction of TRAMP with fibrils. Secondly, the
observations may be genuine, suggesting that the TRAMP-collagen fibril interaction
ceases after long incubation periods. Lastly, the lack of binding fibrils formed in the
presence of TRAMP may be the result of the speed at which the fibrils formed. At
such high starting concentrations of collagen and using the 'warm start' technique, it
is reasonable to expect fibrillogenesis to be essentially instantaneous with no
measurable lag phase. If this is the case, TRAMP may not be able to bind to collagen
before fibrillogenesis commences and therefore cannot be incorporated into fibrils.
The fact that TRAMP is still bound to collagen fibrils after 40 hours at 34°C if no
buffer is added suggests that the first of these possibilities is the most likely.
Partial removal of sulphate groups had no affect on the ability of TRAMP to
accelerate fibril formation, suggesting that tyrosine sulphation is not important for
this function of the protein. However, the possibility that any detrimental effect can
only be observed after complete removal of sulphate groups cannot be ruled out.
Although the role of tyrosine sulphation in proteins remains unclear it has been
suggested that it may be involved in regulating the various activities of
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multi-functional proteins. For example, partial desulphation of fibronectin has no
affect on its gelatin and heparin binding activity but results in a decrease in its ability
to bind fibrin (Suiko and Liu, 1988; section 1.6.2). Thus, tyrosine sulphation may be
important for an as yet unidentified function of TRAMP.
It appears that the binding affinity of TRAMP for collagen I monomers is much
higher than for fibrils. Taking 22kDa and 300kDa as the respective molecular masses
of TRAMP and collagen, and assuming that all TRAMP added to the well binds up
to saturation and that lpg of collagen is bound per well, the highest concentration of
TRAMP (i.e. lOpg/ml) gave a molar ratio of TRAMP to collagen of 27 to 1. This
compares with a 1:2 ratio at saturation for TRAMP binding to collagen fibrils
(Macbeath et al., 1993). The higher affinity of TRAMP for collagen monomers
compared to fibrils supports the theory that this protein is involved in the early
nucleation phase of fibrillogenesis. Macbeath et al. (1993) suggested that TRAMP
facilitated and/or stabilised the assembly of 4D-staggered dimers during the
nucleation phase (section 1.7.2). Assuming that the immobilised collagen is solely
monomelic, has similar binding properties to free collagen and that there is no
self-aggregation of TRAMP, this ratio of TRAMP to collagen monomers would
mean that collagen monomers would be covered with a layer of TRAMP molecules.
However, the low levels of TRAMP found in skin compared to collagen suggest that
this is unlikely to occur in vivo (section 4.1; Chapter 3). The lower affinity of
TRAMP for collagen fibrils may also help to explain the results of the immunogold
labelling of the collagen fibril. If the binding of TRAMP to the fibril is relatively
weak it will be easily displaced by washing steps.
TRAMP is unable to reverse the inhibitory effect of decorin on fibril formation thus
providing evidence that these two ECM components may work together to regulate
the extent of fibril formation. How decorin exerts this effect is unclear. It does not
appear to be the result of displacement of TRAMP from fibrils since the presence of
decorin enhances TRAMP binding to collagen fibrils in TES buffer. Decorin is also
unable to displace TRAMP from collagen monomers or enhance its binding in the
solid phase assay. However, interpretation of the results of the co-sedimentation and
solid phase assays are complicated by the fact that decorin and TRAMP not only bind
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to collagen but also to each other (Okatamo et al., 1996). Thus, the apparent
enhancement of binding to collagen fibrils may be due to TRAMP binding to
collagen via decorin in addition to binding to collagen directly. The fact that no
TRAMP is pelleted after incubation with decorin alone suggests that the increase is
not an artefact caused by precipitation of aggregates of TRAMP and decorin. It is
also of interest to note that in lOmM PBS the presence of decorin has no affect on
binding of TRAMP. Again, this may be the result of the speed of fibril formation at
low phosphate concentrations preventing interactions between TRAMP, decorin and
collagen.
Both the solid phase and co-sedimentation assays suggest separate binding sites for
TRAMP and decorin on collagen since no competition was observed. However, this
could not be confirmed by immunogold labelling of collagen fibrils. Decorin has
been localised to the d and ti bands on positively stained collagen fibrils in vivo
using monoclonal antibodies (Scott and Orford, 1981; Pringle and Dodd, 1990). By
comparison the present study shows no obvious preferred binding sites for TRAMP
on the fibril although a study using monoclonal antibodies would be necessary to
confirm this. Another possible explanation for the lack of results by immunogold
labelling is that the TRAMP is localised in the interior of the fibril and thus its
antigenic sites are not available for antibody binding. Decorin was shown by electron
microscopy followed by rotary shadowing to have 2 binding sites on collagen I
monomers approximately 50 and lOOnm from the N-terminal end of the molecule
(Yu et al., 1993). Similar experiments with TRAMP would be useful to confirm the
separate binding sites of TRAMP and decorin. It should also be noted that at
saturation the levels of binding of decorin to collagen are much lower than for
TRAMP. Hedbom and Heinegard (1989) showed saturation at molar concentrations
of decorin 3 to 4 times that of collagen whilst the highest molar concentration of
TRAMP used in the present study was 27 times greater than that of collagen. It is
therefore possible that collagen has more than 2 binding sites for TRAMP.
Both decorin and TRAMP decrease the diameters of collagen fibrils (Vogel and
Trotter, 1987; Macbeath et al., 1993; section 1.7). In the case of decorin, this is
postulated to be the result of inhibition of the lateral association of collagen
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monomers whereas the end-to-end association of monomers with oligomers and
microfibrils is unaffected (Rosenberg et al., 1993; Danielson et al., 1997). Three
hypotheses have been put forward to explain how TRAMP produces thinner fibrils.
Firstly, it may increase the number of nucleation sites. Secondly, it may alter the
nature of the nuclei so that the axial (i.e. end-to-end) growth is favoured over lateral
growth. Finally, it was suggested that TRAMP may form a circumferential layer
around the fibril once a 'critical' diameter is reached so that further addition of
monomers is blocked (Macbeath et al., 1993). The low levels of TRAMP localised
on collagen fibrils by immunolabelling refutes the last of these hypotheses. If decorin
and TRAMP act on different parts of the fibril assembly mechanism, it is reasonable
to expect them to bind at different sites on the collagen molecule. It also suggests that
in vivo their combined role is not only to regulate the rate of fibril assembly but also
the morphology of the fibrils formed. In addition, this has implications for the
differences in morphology of collagen fibrils from different tissues.
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Chapter 5
Immunological and Enzymatic Studies on TRAMP
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5.1 Immunological studies
Tyrosine rich acidic matrix protein (TRAMP) has previously been shown by western
blot analysis with polyclonal anti-serum to have a widespread tissue distribution in
both murine and porcine tissues (Forbes et al., 1994; section 1.6.3). The aims of the
present study were to look at a wider range of murine tissues using both western
blotting and immunohistochemistry methods.
5.1.1 Immunohistochemistry
5.1.1.1 Methods
Immunohistochemistry procedures described below were carried out by Amanda
Robson, Roslin Institute, Edinburgh. Tissues were removed from freshly killed 21
day old C57 black mice and frozen immediately, either by immersion in isopentane,
previously cooled with solid CCF, or by suspension above liquid nitrogen, followed
by storage at ~80°C. For cryo-microtomy, specimens were attached to chucks with
OCT compound (BDH/Merck) and 10|im sections were cut at -30°C using a Shandon
model OT cryostat. Sections were then transferred to poly-L-lysine coated slides and
endogenous peroxidase activity was blocked with 0.6% (v/v) hydrogen peroxide in
methanol. Slides were indirectly immunolabelled with undiluted affinity purified
antibodies to TRAMP (section 2.7 and 4.2.5) for 2 hours at 4°C, followed by
biotinylated secondary antibody (Vectastain Elite ABC kit). The slides were then
stained with 3,3'-diaminobenzidine (DAB) and 0.09% hydrogen peroxide followed
by light counterstaining with haemotoxylin. Coverslips were placed over the slides
which were mounted with DPX (BDH/Merck). In control slides primary antibody was
replaced either with an irrelevant antibody or with PBS. Additionally, paraffin




Cryo-sections from mouse skin showed diffuse staining for TRAMP throughout the
dermis (Figure 5.1a,b). Diffuse staining was also observed within connective tissues
surrounding the muscle fibres in skeletal muscle sections (Figure 5.1c,d) and in the
endocardium, myocardium, blood vessel walls and supportive tissue of the heart
(Fgure 5.1 h) Strong staining was observed in the serosa and lamina propria of the
duodenum (Figure 5.1 e,f) and in the sclera of the eye (Figure 5.1g). In addition,
TRAMP was localised to the wall of the corpus lutia of the ovary and also within the
kidney (data not shown). No TRAMP was identified in cryo-sections from the testes
and liver (data not shown).
5.1.2 Western blot analysis of murine tissues
5.1.2.1 Methods
Prior to western blot analysis (section 2.4), tissues that had been rapidly frozen for
cryo-microtomy were extracted in 50mM Tris-HCl, 0.15M NaCl, pH 7.5 containing
2% (w/v) SDS and ImM PMSF for 10 minutes at 100°C according to the method of
Kessler et al. (1990). For western blotting a 1:5000 dilution of the anti-TRAMP
antibody was used.
5.1.2.1 Results
Figure 5.2 shows TRAMP to be present in large amounts in murine bladder, ovary
and tail with smaller amounts detectable in testes, skeletal muscle, lung and
duodenum. No TRAMP was detected in extracts from brain, spleen or eye.
5.2 Enzymatic studies
The possible amine oxidase activity of TRAMP (section 1.6.4.3) was investigated
using benzylamine, elastin and collagen substrates. Additionally, attempts were made




Figure 5.1. Localisation of TRAMP in mouse tissues by immunohistochemistry.
(a,b) skin, 1460x. (c,d) skeletal muscle, 1460x. (e,f) duodenum. The serosa (S) and
lamina propria (L) are labelled, (e) I460x, (f) 365x. (g) eye, S represents sclera,
!460x. (h) heart, The endocardium (E) and myocardium (M) are labelled, 1460x.
(a,c,e,g,h) Neat affinity purified anti-TRAMP antibodies. (b,d,f) Controls.
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22kDa
Figure 5.2. Detection of TRAMP in murine tissue extracts by SDS-PAGE and
western blotting. lOOpg protein was loaded in each lane. Electrophoresis was
carried out in reducing conditions with 12% acrylamide in the separating gel.
Antibody detection (1:5000 dilution) was by enhanced chemiluminescence.
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5.2.1 Assays for amine oxidase activity
5.2.1.1 Benzylamine assay
Detection of amine oxidase activity on a benzylamine substrate was carried out as
described by Tabor et al. (1954) in collaboration with Dr. Euan Forbes. Briefly,
20|ig/ml of TRAMP was incubated with ImM benzylamine hydrochloride in 0.1M
sodium phosphate buffer, pH 7.2 in a total volume of 1ml and production of
benzylaldehyde was monitored at 250nm at 25°C in a Phillips PU 8720 UV/VIS
spectrophotometer. Bovine serum amine oxidase (BSAO; Sigma) previously purified
by affinity chromatography on EAH Sepharose 4B (Pharmacia) according to the
method of Houen et al. (1993), was used as a positive control. Partially purified
recombinant human lysyl oxidase (kindly donated by Dr. M. Ouzzine; Ouzzine et al.,
1996) was also assayed. Controls were included with the addition of 0.2mM (3-APN.
5.2.1.2 Lysyl oxidase assay with elastin substrate.
For detection of amine oxidase activity of TRAMP on an elastin substrate, the
ultrafiltration assay described in section 2.1 was used. In general, 2pg of either
TRAMP or a mixture of lysyl oxidase and TRAMP were used in each assay and
controls were included with the addition of 0.2mM (3-APN.
5.2.1.3 Lysyl oxidase assay using a collagen substrate
For detection of amine oxidase activity of TRAMP on a collagen substrate a
modification of the lysyl oxidase ultrafiltration assay (section 2.1) was used. Chick
skin was used as the source of collagen in preference to chick calvaria since lysine
residues in the telopeptide of skin collagen are unhydroxylated (Seyedin and Rosen,
1990). Thus, tritium would not be lost from the 5 position in [4,5 -3H] lysine labelled
collagen during hydroxylation and would be available for assay of lysyl
oxidase/amine oxidase activity (see Figure 1.2).
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5.2.1.3.1 Preparation of [4,5-3H] lysine labelled collagen from chick skin
The method used for preparation of [4,5-3H] lysine labelled collagen was based on
the methods of Siegel (1974) and Payne et al. (1986). The skins from 10 dozen, 17
day old chick embryos (~15g wet weight) were removed and labelled with [4,5-3H]
lysine as described for aortas in section 2.1.1. The skins were washed in Hanks
balanced salt solution (HBSS), chopped up manually using a scalpel and then
homogenised in a glass-teflon homogeniser with ~ 50ml of 50mM Tris-HCl, 1M
NaCl, pH 7.5 containing 20mM EDTA, lOmM NEM and ImM PMSF. The
homogenate was diluted to 200ml with the same buffer and extracted overnight at
4°C with end over end rotation. After centrifugation at 28,000g for 45 minutes the
supernatant was collected and subjected to salt precipitation (to remove collagen III)
with addition of NaCl up to a final concentration of 2M. The precipitate was allowed
to form for 5 hours and again the extract was centrifuged at 28,000g for 45 minutes.
The supernatant was collected and NaCl was added up to a final concentration of
3.5M and left to precipitate overnight. The centrifugation step was repeated and the
pellet was washed in 3.5M NaCl, 50mM Tris-HCl, pH 7.5 containing 20mM EDTA,
lOmM NEM and ImM PMSF, before redissolving in 200ml DEAE-start buffer
(0.2M NaCl, 50mM Tris-HCl, pH 7.5) overnight. The sample was dialysed against
two changes of this buffer and centrifuged at 10,000g for 45 minutes before loading
onto a DEAE-Sephacel column (2.6 x 20cm) at a flow rate of 20ml/hour. Fractions
containing H were pooled (525ml), concentrated to 45ml and dialysed against 2
changes of PBS, pH 7.8.
5.2.1.3.2 Assay for amine oxidase activity on collagen substrate
A modification of the ultrafiltration assay described in section 2.1.2.1 was used to
assay for amine oxidase activity of TRAMP on a collagen substrate. In initial
experiments, lOOpl of 3H collagen was diluted with 700pl of PBS and incubated with
lOOpl of TRAMP (3pg) or PBS at 37°C for 20 hours. However, fibrillogenesis assays
of the assay mixture showed no fibril formation after 4 hours probably due to the
relatively low concentration (156pg/ml) of collagen present in the final assay
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mixture. Thus, to ensure that fibril formation occurred the assay mixture contained
800pl of collagen substrate and 1 OOjul of TRAMP or PBS, giving a final collagen
concentration of 1.25mg/ml. Controls containing 0.2mM (3-APN and buffer alone
were also included.
5.2.2 Results
Table 5.1 summarises the results of amine oxidase assays of TRAMP and lysyl
oxidase on benzylamine, elastin and collagen substrates. Whilst amine oxidase
activity was observed for BSAO in the benzylamine assay and for lysyl oxidase in the
elastin assay after subtraction of (3-APN blanks, TRAMP showed no amine oxidase
activity with either of these substrates. When collagen was used as a substrate,
TRAMP appeared to have some activity after subtraction of the [3-APN blank
(450cpm/ml). However, this value is lower than the background levels obtained for
buffer alone (1390cpm/ml) and thus TRAMP had no measurable amine oxidase
activity on the collagen substrate.
5.3 Detection of quinoproteins by redox-cycling staining
5.3.1 Methods
The procedures described below were carried out by Dr. Euan Forbes.
The method of Paz et al. (1991) was used for detection of quinoproteins by
redox-cycling staining. This method is based on the ability of quinones to oxidise
glycine to form a superoxide which then reduces nitroblue tetrazolium to its formazan
giving rise to a dark blue colour. BSAO previously purified by affinity
chromatography on EAH Sepharose 4B (Pharmacia) according to the method of
Houen et al. (1993) was used as a positive control. TRAMP (lOOpg) and BSAO
(lOOpg) were subjected to SDS-PAGE (section 2.3) and transferred to nitrocellulose
by electroblotting (section 2.4.1.2). Blots were incubated in 2M potassium








- p-APN +P-APN - P-APN +P-APN - P-APN +P-APN
buffer alone 0 0 9490 8760 4780 3390
BSAO 6.5 0 nd nd nd nd
lysyl oxidase 0 0 13420 9700 nd nd
TRAMP 0 0 10680 10810 3740 3290
Table 5.1 Summary of results of assays for amine oxidase activity of TRAMP
and lysyl oxidase on various substrates. It should be noted that in the benzylamine
assay recombinant lysyl oxidase was assayed whilst in the elastin assay a mixture of
lysyl oxidase and TRAMP was assayed, nd = not determined.
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5.3.2 Results
Figure 5.5a shows staining of BSAO but not TRAMP by this method suggesting that
TRAMP is not a quinoprotein.
5.4 Discussion
Previously, TRAMP has been shown by western blotting to be present in murine skin,
lung, cartilage, bone, skeletal muscle, heart and kidney (Forbes et al., 1994; section
1.6.3). In the present study TRAMP was also found to be present in duodenum,
testes, ovary and bladder. Affinity purification of the antibody prior to
immunohistochemistry successfully eliminated the problems of non-specific binding,
(Robson, oral communication) and allowed further localisation of TRAMP within
these tissues to the extracellular matrix. The present study thus confirms that TRAMP
is widespread in connective tissues. In general, there was good agreement between
the results obtained by western blotting and immunohistochemistry with some
exceptions. Firstly, although a positive signal was obtained by western blotting, no
staining was observed within testes and bladder sections by immunohistochemistry.
This may be explained either by the enhanced sensitivity of the western blotting
procedure or by the fact that anti-TRAMP antibodies which had not been affinity
purified were used for western blotting. More difficult to explain is the strong
staining within the sclera of the eye observed by immunocytochemistry and the
negative result for eye extracts by western blotting. It is possible that the antibody
cross-reacts with a low molecular weight species not present after SDS-PAGE with
12% acrylamide in the separating gel. The localisation of TRAMP to the dermis in
skin is in agreement with previous findings for the human equivalent of TRAMP,
dermatopontin (Okamato et al., 1996).
The data presented here suggests that TRAMP does not contain a quinone cofactor
and has no amine oxidase activity. Thus, the ability of TRAMP to stabilise collagen
fibrils against low temperature dissociation (section 1.6.4.2; Macbeath et al., 1993) is
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Figure 5.3. Detection of quinoproteins by redox cycling staining. TRAMP (T; 22
kDa) and bovine serum amine oxidase (B; 90kDa) were subjected to SDS-PAGE
with 12% acrylamide in the separating gel and stained with Coomassie blue (a) or
blotted onto nitrocellulose and stained by redox cycling with 2M potassium
glycinate, 0.24mM nitroblue tetrazolium, pH 10.
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unlikely to be the result of the lysyl oxidase-like activity. The lack of amine oxidase
activity with the collagen substrate contradicts previous, unpublished observations by
Forbes (1994) which suggested that the presence of TRAMP led to the formation of
intramolecular crosslinks (section 1.6.4.3). This may be explained either by the fact
that a different source of collagen was used in the present study or that the TRAMP
used was of higher purity and thus free from contaminating lysyl oxidase. However,
the possibility that this method is not sensitive enough to detect the low levels of
conversion of lysine to allysine cannot be ruled out. Since TRAMP has no detectable
amine oxidase activity and is not a quinoprotein, the presence of the consensus NYD






In the present study TRAMP, free from lysyl oxidase, was successfully purified from
porcine skin although yields remained low. If the denaturing effect of guanidine
hydrochloride on TRAMP is reversible, it may be possible to further improve the
yields of TRAMP by using 4M guanidine hydrochloride in place of urea during the
initial tissue extraction (Okamato et al., 1996). The use of FPLC/HPLC columns
throughout the purification may also help to improve resolution and decrease the time
scale of the purification process. Alternatively, increased yields of TRAMP may be
obtained by development of a bacterial or eukaryotic expression system. Such a
system would also eliminate many of the problems encountered during conventional
purification due to the presence of lysyl oxidase.
The physiological significance of the close association between TRAMP and lysyl
oxidase remains unclear. It would therefore be of interest to examine the interactions
between these two proteins in more detail. This could be achieved by competitive
ELISAs or by density gradient centrifugation. Additional information as to whether
TRAMP and lysyl oxidase interact in vivo may be provided by double
immunolabelling of tissue sections at the electron microscopy level to directly
compare their distributions. However, due to the apparent cross-reactivity of the lysyl
oxidase antibody and the low avidity of the TRAMP antibody this would require the
production of highly specific monoclonal antibodies.
TRAMP has previously been shown to bind collagen I fibrils and accelerate collagen
I fibril formation in vitro (Macbeath et al., 1993). In this study, TRAMP was also
shown to bind collagen I monomers with higher affinity than to fibrils and a role in
the early stages of fibril assembly has been suggested. Future experiments on the
interactions between TRAMP and collagen I monomers should focus on their binding
in solution. This could be achieved using a modification of the solid phase assay used
here (section 4.2.2.2.2) with competition for TRAMP binding between collagen
immobilised on wells and free in solution (Hedbom and Heinegard, 1993). This
would also allow more accurate analysis of binding saturation and the number of
binding sites for TRAMP on collagen. The binding sites of TRAMP on collagen I
monomers could be further investigated by rotary shadowing and electron
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microscopy. Since TRAMP is a relatively small protein it is at the limit of resolution
of this technique and thus visualisation would probably entail the use of an
anti-TRAMP antibody. Additionally, it will be of interest to compare the binding
affinities of other fibrillar and non-fibrillar collagens for TRAMP and to investigate
possible roles of TRAMP in their assembly.
Partial removal of the sulphate groups from TRAMP had no affect on its ability to
accelerate fibril formation in vitro. Future work should focus on the effect of partial
removal of sulphate groups on binding to collagen I monomers and fibrils and to
decorin. Additionally, complete removal of sulphate groups will be necessary to
elucidate more fully whether they have a role in accelerating the fibrillogenesis
process.
Another interesting set of experiments would involve the production of a number of
TRAMP peptides either synthetically, by enzymatic cleavage or using recombinant
methods. These peptides could then be studied in the fibrillogenesis and binding
assays to identify sequences important for the acceleratory effect of TRAMP on fibril
formation and/or for binding to collagen fibrils and monomers.
Although TRAMP is found associated with collagen fibrils in vitro and has been
localised to the extracellular matrix of murine tissues by immunohistochemical
methods, there is no direct evidence to date that TRAMP is localised on or within
collagen I fibrils in vivo. It will therefore be valuable to use immunogold labelling to
localise TRAMP in tissues at the electron microscopy level. As mentioned earlier this
would require the production of highly specific, monoclonal antibodies to TRAMP to
overcome the problems encountered during immunogold labelling of in vitro
reconstituted collagen fibrils. It will also be important to check that the inability to
identify specific binding sites for TRAMP on collagen fibrils formed in vitro is not
due to masking of antigenic sites by closely packed collagen molecules, as is the case
with heterotypic fibrils of collagens I and V (Birk et al., 1988). To do this the fibrils
should be treated with acetic acid or collagenase to disrupt the fibril structure prior to
commencing the labelling procedure.
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The results of the present study suggest that the interactions between TRAMP,
decorin and collagen I are complex. They are also of particular interest given the
profound effect of decorin gene "knockouts" on the supramolecular architecture and
spatial arrangement of collagen fibrils within the skin (Danielson et al., 1997).
Double immunogold labelling of TRAMP and decorin at the electron microscope
level may give further insight into the interplay between these ECM components.
Additionally, identification of the binding site(s) of TRAMP on decorin, with
particular reference to the three-dimensional shape of this SRLP and its proposed
modes of interaction with collagen I, may provide important pointers as to the role of
TRAMP in fibril assembly. Likewise, comparisons of the binding sites of decorin and
TRAMP on collagen I monomers and fibrils and elucidation of the binding sites of
decorin on TRAMP will help to complete the picture. It may even be possible to
study the decorin-TRAMP-collagen complex by rotary shadowing. The potential
interactions of TRAMP with other members of the SRLP family could also be
investigated.
The results of western blotting and immunohistochemical studies presented here
confirm previous reports that TRAMP is a widely distributed connective tissue
constituent. In the future, further understanding of the role(s) of TRAMP in the ECM
may also be gained by studying the developmental localisation and expression of
TRAMP in murine tissues using the above methods and also by Northern blotting or
in situ hybridisation. Additional studies on the distribution and expression levels of
TRAMP in tissues from patients with hereditary connective tissue disorders may
serve to implicate TRAMP gene mutations in these diseases.
One possible function of TRAMP which was not addressed in the current work is its
role in the attachment of cells to the ECM. Possible cell surface receptors for
TRAMP could thus be identified, by subjecting detergent cell extracts to
chromatography on a TRAMP affinity column. An alternative and perhaps more
labour intensive approach would be to use antibodies to the various classes of
integrins in order to block cell adhesion of TRAMP to mouse 3T3 cells or human
dermal fibroblasts.
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In the future, a more effective way to study the function(s) of TRAMP in the
extracellular matrix may be to look at the supramolecular architecture of the matrix
after TRAMP gene disruption or knockout experiments.
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Appendix
Localisation of procollagen C-proteinase enhancer in murine tissues
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Al. Introduction
The procollagen C-proteinase enhancer (PCPE) is a 55kDa glycoprotein which
enhances the activity of procollagen C-proteinase/bone morphogenetic protein-1
(BMP-1; Kessler and Adar, 1989; section 1.2.2). Both 34kDa and 36kDa fragments
of PCPE have also been identified although their physiological significance remains
to be elucidated (Adar et al., 1986). PCPE has previously been shown by western
blotting and RNase protection to be widespread within connective tissues (Kessler et
al., 1990; Takahara et al., 1994). The aims of the current study were to test a number
of other murine tissues for the presence of PCPE by western blotting. The results of
western blots could then be compared to concurrent investigations by
immunocytochemical localisation carried out by Amanda Robson.
A2. Western blotting
Tissues which had been removed from 21 day old C57 black mice and rapidly frozen
for cryo-microtomy were extracted as described in section 5.1.2.1 and subjected to
SDS-PAGE and western blotting (section 2.4). The primary antibody (obtained from
Dr. E. Kessler) had previously been raised against the 36kDa fragment of PCPE and
affinity purified as described in section 2.7. This antibody was used at a 1:500
dilution.
The results confirm previous reports of the presence of PCPE in skeletal muscle and
eye. In addition, the present study showed PCPE to be present in lung, testes, ovary
and bladder (Figure Al).
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Figure Al. Detection of PCPE in murine tissue extracts by SDS-PAGE and
western blotting. lOOpg protein was loaded in each lane. Electrophoresis was
carried out in reducing conditions with 10% acrylamide in the separating gel.
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